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Foreword    
Welcome the 2016 Severe Maternal Morbidity 
(SMM) Report from the National Perinatal 
Epidemiology Centre (NPEC). The most 
heartening aspect about this report is the 
commendable commitment of the busy Irish 
maternity units to go beyond clinical care 
and contribute to this national audit in order 
to help improve maternal care for women in 
Ireland. Working and learning together we 
can ensure that all pregnant and recently 
pregnant women receive safe high quality 
care in appropriate settings.
While the maternal mortality rate in Ireland 
is comparatively low, there has been an 
increasing incidence of severe maternal 
morbidity reported in recent years, particularly 
the incidence of major obstetric haemorrhage. 
This is similar to findings in other high income 
countries and highlights the importance of 
continual surveillance of maternal outcomes 
in our maternity services. However, it is 
important that we do not focus on rates and 
numbers alone. We should remember that 
severe maternal morbidity events can have a 
profound psychological effect on a woman’s 
and her partner experience of childbirth. 
A positive development to highlight is 
the implementation of recommendations 
from earlier maternal morbidity reports. All 
maternity units in the Republic of Ireland now 
contribute data to the NPEC audit on severe 
maternal morbidity. Recently, the interaction 
with the National Women and Infant’s Health 
Programme (NWIHP) in assessing our 
recommendations with a view to implement 
nationally, has been a most welcome 
development. 
This report adds to a body of evidence to 
allow us to make international comparisons 
and learn more about maternal morbidity 
in Ireland. I commend that all healthcare 
professionals involved in the maternity 
service be aware of the findings in this report. 
Richard A Greene, Director, NPEC
National Perinatal Epidemiology Centre
5th Floor, Cork University Maternity Hospital
Wilton, Cork, Ireland
Email: npec@ucc.ie
Tel: +353 (21) 420 5017
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Executive summary 
The fifth report from the National Clinical 
Audit of Severe Maternal Morbidity (SMM) 
in Ireland reports on 406 cases of SMM 
occurring in all 19 Irish maternity units 
in 2016. Additionally, it presents findings 
from the Confidential Audit of Critical Care 
in Obstetrics in Ireland 2016. Fifteen of 19 
Irish maternity units participated, including 
two large tertiary referral units and thirteen 
smaller units. 
The SMM rate is a composite rate of a group 
of clearly defined severe morbidities. Almost 
three quarters of the women (n=293, 
72.2%) who experienced SMM in 2016 were 
diagnosed with one morbidity; 21% (n=85, 
20.9%) were diagnosed with two morbidities; 
6% (n=23, 5.7%) with three morbidities; and 
1% (n=5, 1.2%) with four morbidities.
Since the inception of the audit in 2011, the 
incidence of SMM has increased annually. In 
2016, the rate of SMM was 6.46 per 1,000 
maternities or one in 155 maternities. This 
represented a 68% rate increase from the 
base year 2011. However, the Irish SMM 
rate in 2016 was similar to the rate of 7.3 
per 1,000 maternities reported by the most 
recent comparable audit in Scotland in 2012, 
which used the same composite rate for 
SMM.
Major obstetric haemorrhage (MOH) remains 
the most frequently reported SMM event in 
2016, accounting for just over half (53%) of 
SMM cases. The incidence of MOH cases has 
increased from 2.34 per 1,000 maternities in 
2011 to 3.39 per 1,000 maternities in 2016, 
an overall increase of 45% (rate ratio=1.45, 
95% CI=1.18-1.77, p-value<0.001), which is 
highly statistically significant.
Admission to an intensive or coronary care 
unit (ICU/CCU) was the second most common 
event, having been reported in over a third 
(39.4%) of SMM cases. Just over one third 
(34.4%) of the women admitted to an ICU/
CCU in 2016 had not experienced a SMM as 
defined in this audit. This shows a reduction 
in the occurrence of this phenomenon 
(recording 46% in 2015) which had shown 
a steady increase over the past years of the 
audit. 
The next most common reported morbidities 
were renal or liver dysfunction (8.4%), 
septicaemic shock (6.9%), peripartum 
hysterectomy (6.7%) and pulmonary 
embolism (5.9%).
In 2016, the number and rate of cases for 
each SMM excluding MOH, ICU/CCU admission 
and septicaemia were broadly in line with 
those reported in 2011-2015. The rate of 
septicaemic shock in 2016 (0.45 per 1,000 
maternities) was almost double the rate for 
2011-2015 (p-value=0.005). The successive 
increases observed since 2013 may be a 
true increase in incidence or an increased 
awareness and recognition of sepsis.
The incidence of peripartum hysterectomy 
(PH) in 2016 showed a moderate 
increase (0.43 per 1,000 maternities or 
approximately one in approximately 2,300 
maternities). This was still within the range 
that might be expected based on previous 
years and is similar to the rate in the United 
Kingdom (0.41 per 1,000 births). Abnormal 
placentation, primarily morbidly adherent 
placenta, was the most commonly reported 
indication for PH (74.1%).
Variation in rates of SMM and MOH were 
identified between units. However, 
differences between units must be 
interpreted with caution, as they are 
possibly related to differences in the risk 
profile of pregnant women presenting to the 
units rather than the care given. Variances 
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in rates of MOH between units may also 
reflect variances in practices of estimating 
blood loss.  We have reflected on methods 
of estimating blood loss in units with high 
and low rates of MOH and observed a lack of 
standardisation.
One unit had a MOH rate above the 95% upper 
limit for the national rate of 3.39 per 1,000 
maternities. This unit has been notified 
in accordance with the National Office of 
Clinical Audit (NOCA) escalation process.
Three units with high MOH rates in 2015 
followed the NOCA escalation process and 
reviewed their data and related clinical 
practices. One unit was found to have 
overestimated their number of MOH cases. 
One unit implemented quality improvement 
initiatives including increased training for 
staff and use of a specific proforma in the 
event of post-partum haemorrhage. The 
third unit confirmed that their quantitative 
approach for estimating blood loss led to 
effective case ascertainment.
The perinatal mortality rate (PMR) among 
infants born to women who experienced SMM 
was 39.1 per 1,000 births, i.e. one in 25 of 
the infants died. This is approximately seven 
times the perinatal mortality rate observed 
for all births in Ireland.
Similar to previous years, multiple 
pregnancy was associated with an almost 
fourfold increased risk of morbidity. The SMM 
rate associated with multiple pregnancy 
was 23.85 per 1,000 maternities compared 
to a rate of 5.77 per 1,000 maternities for 
singleton pregnancy in 2016.  
In the Confidential Audit of Critical Care 
in Obstetrics in Ireland, the incidence of 
women requiring Level 2 Care was 8.7 per 
1,000 maternities or one in 114 maternities. 
The number of women requiring Level 3 Care, 
either solely or in combination with Level 2 
Care, was 0.47 per 1,000 maternities or one 
in 2,127 maternities.
While the location of care for women requiring 
Level 3 Care was in an ICU/CCU facility, the 
location of care for women requiring Level 2 Care 
varied depending on the size of the maternity 
unit.  Smaller maternity units, recorded greater 
utilisation of ICU/CCU facilities. The type of organ 
support required and underlying pathology are 
detailed in this report.
Severe maternal morbidity
• There was a statistically significant 
increase in the rate of Severe Maternal 
Morbidity (SMM) and major obstetric 
haemorrhage (MOH) in 2016 compared 
to the base year 2011.
• The rate of SMM was 6.46 per 1,000 
maternities or one in 155 maternities.
• MOH remains the most commonly 
reported morbidity. 
• Variation in rates of SMM and MOH were 
identified between units.
• Multiple pregnancy was associated 
with an almost fourfold increased risk 
of SMM
• The perinatal mortality rate among 
infants in women experiencing SMM 
is approximately seven times the rate 
observed for all births in Ireland.
 
 
Confidential Audit of Critical Care in 
Obstetrics in Ireland
• One in 109 women required either Level 
2 Care and/or Level 3 Care. 
• The need for higher levels of maternal 
care is not predictable in approximately 
half of cases and thus has implications 
for resource planning.
Key findings in 2016:
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Introduction
This is the fifth report of the national clinical 
audit on severe maternal morbidity (SMM) 
in the Republic of Ireland (ROI). SMM has 
been acknowledged internationally as an 
important quality indicator of obstetric 
care and maternal welfare, particularly in 
developed countries where maternal death 
rates are relatively low. Further, there is 
evidence that commonly occurring life-
threatening complications during or shortly 
after pregnancy, such as major obstetric 
haemorrhage (MOH), are under reported as 
they less frequently lead to death in high-
resourced countries. In this context, the 
NPEC in collaboration with the NPEC Maternal 
Morbidity Group, has collected and analysed 
data on SMM from Irish maternity units since 
2011. The fundamental aim of the audit is to 
provide a national review of clearly defined 
severe maternal morbidities, to identify 
quality improvement initiatives and make 
recommendations for the improvement of 
maternal care for women in Ireland.   
The report is divided into two sections 
(Figure I) with additional information 
provided in the Appendices. Section One 
provides information on the occurrence of 
clearly defined severe maternal morbidities 
occurring in Ireland in 2016. 
Section Two presents findings from the 
Confidential Audit on Critical Care in 
Obstetrics in Ireland in 2016. This latter 
audit compliments the SMM audit to further 
evaluate maternal outcomes. Commenced in 
2014, the purpose of this audit is to address 
the dearth of national data on prevalence 
rates for women who require Level 2 Care 
and Level 3 Care and the location where 
these higher levels of care are provided. 
The audit compliments the Intensive Care 
National Audit and Research Centre (ICNARC) 
and is the second in a series of topic specific 
case assessment audits conducted by the 
NPEC on a triennial basis. 
Figure I: Sections of this 2016 Severe Maternal Morbidity Report.
Section 1 contains the main findings of the  
Severe Maternal Morbidty (SMM) audit including
Section 2 contains findings from the Confidential Audit  
of Critical Care in Obstetrics in Ireland
• National and international comparisons of SMM rates
• Prevelance of specicific SMM
• Distribution of SMM by Robson Ten Group Classification System
• Maternal characteristics, management of delivery and neonatal outcome 
 in women experiencing SMM
• ICU admission and Level of Care provided to women experiencing SMM
•  Specific findings for women who required Level 2 Care only
•  Specific findings for women who required Level 3 Care 
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Recommendations
• Formal counselling support should be 
made available for all women and their 
partners following a severe maternal 
morbidity: this is already currently 
available in some units but not all.
• The NPEC endorses the multidisciplinary 
training in the management of 
postpartum haemorrhage advocated 
by the National Clinical Programme 
for Obstetrics and Gynaecology. We 
recommend the development and 
national implementation of a specific 
proforma to improve management and 
documentation during a major obstetric 
haemorrhage event, whether in the 
antenatal or postnatal period.
• A quantitative approach involving 
volume and weight assessment 
to estimate blood loss should be 
considered for use in all maternity 
units. Development of a national tool-kit 
would assist standardisation of such an 
approach.
• The location where critical care for the 
pregnant or recently pregnant woman 
is provided varies across maternity 
units according to available resources: 
in small units, critical care is often 
provided in the Intensive Care Unit/
Critical Care Unit (ICU/CCU). It is thus 
recommended that in such units, the 
appropriate resources and training 
for the care of the critically ill woman 
in obstetrics are in place within the 
ICU/CCU. For maternity units with 
greater than 2,500 births per annum, 
consideration should be given to 
resourcing the unit with the capacity to 
provide Level 2 Care.
• All pregnant or recently pregnant 
women should have equitable access to 
the most appropriate critical care facility 
for her needs and a national maternal 
retrieval service should be provided. 
This supports the recommendations of 
the National Maternity Strategy.1
• A structured notification system 
between ICU departments and the 
maternity unit responsible for a 
woman’s care during pregnancy 
should be developed to improve 
communication. 
1 Department of Health. Creating a Better Future Together: National Maternity Strategy, 2016-2026. Dublin; 2016
Recommendations from previous reports being addressed by the National 
Women’s and Infants Health Programme.
The following recommendations have been escalated to the National Women’s and Infants 
Health Programme and are being progressed.
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• Robust clinical audit on adverse 
maternal outcomes requires the 
protected time of clinical staff. Funding 
should be provided by the Health 
Service Executive (HSE) to facilitate 
same.
• The Robson Ten Group Classification 
System (TGCS) is a method providing 
a common starting point for further 
detailed analysis within which all 
perinatal outcomes can be measured 
and compared. The NPEC encourages 
all units to collect TGCS data in order to 
facilitate local and national audit. 
• A public health education programme 
on maternal morbidity and modifiable 
risk factors should be developed.
• Maternal Newborn Clinical Management 
System (MN_CMS) data from Irish 
maternity units should be collated to 
identify the influence of risk factors 
for SMM in Ireland including: ethnicity, 
maternal age, body mass index (BMI), 
smoking and employment status.
• There is a need to review the SMM audit 
components and definitions with a view 
to enhancing the quality of data and 
lessons for care. This in keeping with 
best practice and will be actioned by 
the NPEC SMM group.
• To facilitate and enhance the scope of 
audit, a national standardised approach 
to obtaining consent for processing 
data from service users should be 
considered in light of the recent General 
Data Protection Regulation (GDPR) 
2016.2
2  European Data Protection Law. General Data Protection Regulation 2016. Available at www.eu-gdpr.org
Based on findings from this and previous reports, the NPEC Severe Maternal 
Morbidity Group makes the following recommendations:
The following recommendations have been escalated to the National Women’s and Infants 
Health Programme and are being progressed.
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Figure II: Map of maternity units and hospital groups in the Republic of Ireland
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• Robust clinical audit on adverse 
maternal outcomes requires the 
protected time of clinical staff. Funding 
should be provided by the Health Service 
Executive (HSE) to facilitate same.
• To enhance the scope of audit, 
a national standardised approach to 
obtaining consent for processing data 
from service users should be considered 
in light of the recent General Data 
Protection Regulation (GDPR) 2016. 
Methods
To allow for international comparison, the 
NPEC adapted the validated methodology 
of the Scottish Confidential Audit of Severe 
Maternal Morbidity (SCASMM) to evaluate 
severe maternal morbidity (SMM) in Ireland. 
This methodology utilises organ dysfunction 
criteria described by Mantel et al,3 with 
modifications used by SCASMM to include 
intervention based criteria.4 Implemented 
nationally in 2011, this data collection tool, 
adapted for the Irish setting, has been 
endorsed by the Clinical Advisory Group at 
the Institute of Obstetrics and Gynaecology 
and the HSE National Obstetric Programme 
Working Group. 
Data recording
Since the inception of the audit in 2011, all 
but one maternity unit has contributed data 
for the years 2011, 2012, 2014 and 2015, with 
all maternity units submitting data for the 
years 2013 and 2016. In 2016, there were 19 
maternity units in the Republic of Ireland. Data 
on SMM events occurring between 1 January 
and 31 December 2016 were submitted using 
a standardised notification dataset, either 
electronically via the secure online NPEC 
database or alternatively by paper format 
(See Appendix E).  The dataset is completed 
based on data on maternal and fetal 
characteristics recorded in clinical records. 
The data are subsequently processed by NPEC 
in a pseudonymised format, which means 
that they cannot be attributed to a specific 
individual without the use of additional 
information, and only the submitting unit has 
access to this information. 
Revised data for 2015
In this report, comparisons are made between 
SMM cases in 2016 and those of previous 
years, in particular 2015. The SMM Annual 
Report for 2015 specified that there were 381 
cases in that year. As part of the clinical audit 
process, some maternity units were asked 
to review their SMM cases registered for 
2015. This identified nine cases that did not 
meet case inclusion criteria. While these nine 
cases were included in the Annual Report for 
2015, they have been removed from the SMM 
database. Findings specified for 2015 in the 
current report are based on the 372 cases in 
the revised database for 2015.
3 Mantel G et al. Severe Acute maternal morbidity: a pilot study of a definition for a near-miss. BJOG 1998; 105: 985-90
4  Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
 Recommendations:
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Figure III: NPEC data collection and management processes.
Definitions and inclusion criteria  
for audit
In this audit, a case of severe maternal 
morbidity (SMM) was defined as a pregnant or 
recently-pregnant woman (i.e. up to 42 days 
following the pregnancy end) who experienced 
any of the following seventeen, clearly defined, 
maternal morbidities in the reporting years 
2012-2016: major obstetric haemorrhage 
(MOH), uterine rupture, eclampsia, renal or 
liver dysfunction, pulmonary oedema, acute 
respiratory dysfunction, pulmonary embolism, 
cardiac arrest, coma, cerebrovascular event, 
status epilepticus, septicaemic shock, 
anaesthetic complications, other morbidity 
and maternities involving peripartum 
hysterectomy, ICU/CCU admission and 
interventional radiology. Definitions for these 
morbidities are provided at the end of the 
notification form (Appendix E).
The ‘other severe morbidity’ category was 
included to explore whether further specific 
morbidities warrant inclusion in the audit. 
Findings are not provided in this report for 
cases in this category unless one of the other 
specified morbidities was also experienced.
In 2012-2016, uterine rupture was a specified 
morbidity for the audit whereas this was not 
the case in 2011, the first year of the audit. 
This change has led to a small increase in 
reportable cases of SMM. However, most 
cases of uterine rupture meet the criteria 
for major obstetric haemorrhage and were 
therefore reported in all six years of the audit.
Definitions and classification of the 
critically ill woman in Obstetrics
In January 2014 an audit on Critical Care in 
Obstetrics in Ireland was initiated by the NPEC 
for the triennium 2014-2016. Levels of care 
Severe Maternal  
Morbidity Event
Dataset Completed and  
Submitted to the NPEC
Data Quality Assurance  
and Management
Dissemination
Development and production 
of Annual Severe Maternal  
Morbidity Report
Severe maternal morbidity event
• Maternity unit completes NPEC Severe Maternal Morbidity Notification Dataset.
• Unit Coordinator submits data to the NPEC with possible  contribution of  
 Midwives, Obstetricians and Anaesthetists.
• NPEC data manager reviews and validates all data with unit co-ordinator.  
 Data cleaning.
• Dissemination of unit specific reports to all maternity units.
• Dissemination of the national report to various stakeholders including the  
 Department of Health and the public. 
• Data analysis and report writing.
• Review and endorsement of the report by: NPEC Severe Maternal Morbidity  
 Group, NPEC Governance Committee and the National Office of Clinical Audit.
Figure III illustrates the NPEC data collection 
and management processes. There has been 
a steady improvement in the overall quality 
of data reported by maternity units since the 
implementation of the NPEC SMM notification 
dataset in 2011.
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5 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and 
Gynaecologists,  Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health 
Service Executive
6 The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM. World Health Organisation 
2012
7 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World 
Health Organization; 2011
8 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122.
9 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2016. (in press) Dublin: Health Service Executive. In Press
10 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
were defined using National Guidelines for the 
Critically Ill Woman in Obstetrics (Appendix F).5 
Fifteen of 19 Irish maternity units contributed 
to this audit for the years 2014 - 2016, 
including two large tertiary referral maternity 
units and thirteen smaller maternity units. 
In the case of a woman requiring Level 2 or 
Level 3 Care, participating units were asked to 
complete an additional form (Appendix G). The 
main clinical diagnosis, organ support required 
and specialist review during the critical 
care event were documented on this form. 
Additional data on maternal demographics and 
neonatal outcomes were reported on the NPEC 
SMM notification form (Appendix E). 
Maternal morbidity was classified as direct, 
indirect or coincidental based on the main 
clinical diagnosis during the critical care 
event, using the WHO classification for 
maternal mortality (Appendix H).6 Morbidity 
was further categorised using three different 
models for defining maternal morbidity: (a) 
the NPEC SMM methodology which utilises 
organ dysfunction and management based 
criteria, (b) the WHO organ-dysfunction criteria 
defined as Near Miss (NM)7 (Appendix I) and 
(c) the WHO disease specific criteria Severe 
Maternal Complications (SMC) (Appendix J).
Robson Ten Group Classification 
System
In 2016, 13 of the 19 units that participated in 
the SMM audit also provided data on deliveries 
classified according to the Robson Ten Group 
Classification System8 (TGCS; Appendix K). 
The incidence of MOH and other SMM were 
classified according to the TGCS for these 13 
units. The deliveries in these units constituted 
80.0% of the 62,871 deliveries in Ireland in 2016.
Rate calculations
The SMM rate is a composite rate of a group of 
clearly defined severe morbidities. In keeping 
with the international published literature 
in this area, the incidence rate of SMM 
and of specific morbidities are calculated 
per 1,000 maternities resulting in the live 
birth or stillbirth of a baby weighing at least 
500g. For incidence rates, 95% confidence 
intervals were calculated using the Normal 
approximation of a binomial proportion 
confidence interval.
Denominator data on the number of 
maternities were provided by the Healthcare 
Pricing Office (HPO).9 The denominator 
underestimates the number of women at 
risk of SMM as it does not include women 
experiencing miscarriage, ectopic pregnancy 
and molar pregnancy, which may be reported 
as cases of SMM and thereby are included in 
the numerator. However, complete data on 
maternities resulting in miscarriage, ectopic 
pregnancy and molar pregnancy are not 
available and so, to ensure uniformity, the 
denominator was restricted to live births and 
stillbirths of babies weighing at least 500g. 
The approach of not including miscarriage, 
ectopic pregnancy and molar pregnancy in 
the denominator was also the approach taken 
by the SCASMM.10
Funnel plots are used to illustrate both 
the variation in incidence rates across 
participating maternity units and the 
deviation of the rate for each individual unit 
from the national rate. 
Further analysis was conducted to assess 
variation in incidence rates between years, 
maternal age groups, and single and multiple 
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
 19
11 Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
pregnancies. This analysis involved using 
Poisson regression which calculates a rate 
ratio (for example, the rate in one year 
divided by the rate in the previous year). 
Rate ratios have the advantage of being easy 
to interpret. A rate ratio is greater than one if 
a rate is greater than the rate to which it is 
being compared. For example a rate ratio of 
1.25 indicates the rate being examined is 25% 
higher than (or 1.25 times) the rate to which it 
is being compared. Conversely, a rate ratio will 
be less than one if a rate is less than the rate 
to which it is being compared. For example a 
rate ratio of 0.80 indicates that the rate being 
examined is equivalent to 80% of the rate to 
which it is being compared, i.e. it is 20% lower. 
The Poisson regression analysis provides 
a 95% confidence interval for the rate ratio 
and the associated p-value, both of which 
indicate whether the rate difference is in line 
with what might be expected due to chance. 
A rate difference is considered to be beyond 
what might be expected by chance, i.e. 
statistically significant, if the 95% confidence 
interval for the rate ratio does not include the 
value one. This is equivalent to the p-value 
derived from the analysis being less than 
0.05. If the p-value is less than 0.001 then 
the rate difference may be considered highly 
statistically significant.
Funnel plots
Variations in SMM between maternity units 
could potentially be due to random chance or 
reflect differences in baseline characteristics 
of the childbearing population. For this reason, 
funnel plots were used to assess performance 
outcomes for individual units in comparison 
to the overall average.11 In brief, the plot is a 
scatter diagram of individual maternity unit 
SMM rates against the number of maternities 
within that unit. The national rate is indicated 
by the solid straight line. The 95% confidence 
interval is indicated by the curved dashed 
line. The dashed lines represent the limits 
within which 95% of units are expected to 
lie (i.e. within two standard deviations). The 
99.8% confidence interval for the national 
rate is plotted using solid lines. These solid 
lines represent the limits within which 
99.8% of units are expected to lie (i.e. within 
three standard deviations). The width of the 
confidence interval is adjusted to allow for 
meaningful comparison between unit-specific 
rates and the national rate. The confidence 
interval is wider for smaller units reflecting 
the lack of precision in rates calculated based 
on small numbers. The confidence interval 
narrows for larger maternity units, giving 
the diagram a ‘funnel’ shape. Maternity unit 
rates outside the 95% and 99.8% confidence 
interval are statistically significantly different 
from the national rate. In general, one in 20 
units would be expected to lie outside the 95% 
confidence limits by chance alone whereas 
an observation outside the 99.8% confidence 
limits is especially rare, i.e. there is a 0.2% 
chance of this happening.
Some of the variation in rates across maternity 
units will be due to differences in the profile 
of the women attending the maternity units. 
Data are not available to allow for adjustment 
of the profile of women attending the 
country’s maternity units. For this reason, 
we recommend conservative interpretation 
of differences between the rates of units and 
their deviation from the national rate.
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Main Findings
In 2016, the nineteen participating maternity 
units reported that 406 women experienced 
SMM as defined in this audit. Table 1 details the 
national number of cases, total maternities and 
SMM rates derived from the participating units in 
each of the six years of the audit, 2011-2016.
From 2011 to 2016, the SMM rate varied 
from 3.83 to 6.46 per 1,000 maternities or 
from one in 261 maternities to one in 155 
maternities. Respectively, the SMM rate was 
16%, 24%, 55%, 62% and 68% higher in 2012, 
2013, 2014, 2015 and 2016 than in the base 
year 2011. 
A comparable national audit in Scotland for 
the years 2003-2012, which uses the same 
composite rate for SMM as this audit, reported 
an SMM rate of 7.3 per 1,000 maternities 
for 2012.12 The Irish SMM rate in 2016 was 
similar to the most recent Scottish rate (rate 
ratio=0.89, 95% CI=0.78-1.02, p-value=0.094).
The increase in SMM rate mirrors a continual 
increase in major obstetric haemorrhage 
(MOH) rate. It may also reflect an improvement 
in case ascertainment of MOH.
National rate
Table 1: Incidence of severe maternal morbidity (SMM) in Ireland, 2011-2016
Note: Maternities excluding those in one non-participating unit in 2011, 2012, 2014 and 2015. CI= confidence interval. Poisson 95% confidence intervals 
were calculated for the rate and rate ratios. *Cases of uterine rupture exclusive of major obstetric haemorrhage were not reported for 2011.
 2011* 2012 2013 2014 2015 2016
Maternities in  67,806 65,768 68,047 61,593 60,006 62,871
participating units 
SMM cases 260 292 323 365 372 406
SMM rate 3.83 4.44 4.75 5.93 6.20 6.46
(95% CI) (3.36-4.31) (3.92-4.96) (4.22-5.27) (5.31-6.54) (5.59-6.84) (5.85-7.12)
Rate ratio 1.00 1.16 1.24 1.55 1.62 1.68
(95% CI) (Ref.) (0.98-1.37) (1.05-1.46) (1.32-1.81) (1.38-1.89) (1.44-1.97)
p-value  0.086 0.011 <0.001 <0.001 <0.001
Section 1: Severe maternal morbidity audit
12 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx 
The SMM rate is a composite rate of a group 
of clearly defined severe morbidities. Almost 
three quarters of the women (n=293, 72.2%) 
who experienced SMM in 2016 were diagnosed 
with one morbidity; 21% (n=85, 20.9%) were 
diagnosed with two morbidities; 6% (n=23, 
5.7%) with three SMMs; and 1% (n=5, 1.2%) 
with four morbidities.
In the first three years of the NPEC SMM audit, 
MOH was the most frequently reported SMM 
event. In 2014 and 2015, admission to an 
intensive or coronary care unit (ICU/CCU) was 
as common as MOH. MOH was again the most 
commonly reported morbidity in just over half of 
the SMM audit cases in 2016 (Table 2). The next 
most common reportable SMM events were 
renal or liver dysfunction (8.4%), septicaemic 
shock (6.9%), peripartum hysterectomy (6.7%) 
and pulmonary embolism (5.9%).
The incidence of eclampsia in Ireland remains 
low (0.22 per 1,000) and compares favourably 
with the values in UK (0.27 per 1,000) and 
Specific morbidities
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13 Schaap, T. P., Knight, M., Zwart, et al. (2014). Eclampsia, a comparison within the International Network of Obstetric Survey Systems. Bjog, 121(12), 1521-1528.
14 Vandenberghe, G. , et al. (2018), The INOSS study of uterine rupture: a descriptive multi‐country population based study. BJOG: Int J Obstet Gy. Accepted 
Author Manuscript.
15 Department of Health (2014) Sepsis management. Guideline No 6 
16 Lawson B, Nair M, Kochanski P, Kurinczuk JJ, Knight M. UKOSS Annual Report 2017. Oxford: National Perinatal Epidemiology Unit 2017
Table 2: Incidence of specific severe maternal morbidities (SMMs) in Ireland, 2011-2016
Note: n represents number of women affected by the specific morbidity; more than one morbidity may apply per woman % is based on the total number of 
women affected; rate is per 1,000 maternities; 95% CI=95% confidence interval; ICU=intensive care unit; Uterine rupture was not recorded by the audit in 
2011 unless associated with MOH.
Netherlands (5.4 per 10,000) for 2014.13 
When comparing to European rates, the Irish 
values for uterine rupture (1.3 per 10,000) 
also rank as one of the lowest rates across 
several countries (Austria reported the lowest 
prevalence among all the countries studied 
with 1.6 per 10,000 deliveries).14
In 2016, the number and rate of cases for each 
SMM other than MOH and ICU/CCU admission 
were broadly in line with those reported 
in 2011-2015 (Table 2). An exception was 
septicaemic shock, the rate in 2016 was almost 
double the rate for 2011-2015 (rate ratio=1.86, 
95% CI=1.21-2.87, p-value=0.005). Very few 
cases of septicaemic shock were reported 
in 2011 and 2012 but there were notable and 
successive increases in 2013, 2014 and 2015. 
This may be a true increase in incidence or may 
be associated with an increased awareness 
and recognition of sepsis with the development 
of the National Sepsis Guideline.15
Recent reports on maternal mortality in 
Ireland and the UK have identified thrombosis/
thromboembolism as a leading direct 
obstetric cause of maternal death. At 0.38 per 
1,000 maternities or one in 2,620 women, 
the incidence of pulmonary embolism (PE) in 
2016 was higher though still in line with the 
rate in 2011-2015. This value was also higher 
than the reported PE rate in the UK (1.4 per 
10,000 maternities).16 Notwithstanding, we 
believe the current Irish rate may represent 
an underestimate as many post-natal cases 
will be unknown to maternity units as the 
women present to general hospitals: the 
maternity services may not be aware of the 
event. The NPEC Severe Maternal Morbidity 
Group have endeavoured to develop a 
2011-2015 2016
n(%) Rate(95% CI) n(%) Rate(95% CI)
Major obstetric haemorrhage 850(52.7) 2.67(2.49-2.86) 215(53.0) 3.39(2.92-3.85)
ICU/coronary care unit admission 725(45) 2.28(2.11-2.45) 160(39.4) 2.54(2.14-2.95)
Renal or liver dysfunction 152(9.4) 0.48(0.4-0.56) 34(8.4) 0.54(0.36-0.73)
Septicaemic shock 76(4.7) 0.24(0.18-0.29) 28(6.9) 0.45(0.28-0.61)
Peripartum hysterectomy 102(6.3) 0.32(0.26-0.38) 27(6.7) 0.43(0.26-0.59)
Pulmonary embolism 79(4.9) 0.25(0.19-0.3) 24(5.9) 0.38(0.23-0.54)
Acute respiratory dysfunction 37(2.3) 0.15(0.1-0.2) 14(3.4) 0.22(0.1-0.34)
Eclampsia 51(3.2) 0.16(0.12-0.21) 14(3.4) 0.22(0.1-0.34)
Pulmonary oedema 44(2.7) 0.14(0.1-0.18) 12(3.0) 0.19(0.08-0.3)
Uterine rupture 45(2.8) 0.14(0.1-0.18) 8(2.0) 0.13(0.04-0.22)
Interventional radiology 33(2) 0.10(0.07-0.14) 5(1.2) 0.08(0.01-0.15)
Anaesthetic problem 20(1.2) 0.06(0.03-0.09) 5(1.2) 0.08(0.01-0.15)
Cerebrovascular event 21(1.3) 0.07(0.04-0.09) 4(1.0) 0.06(0-0.13)
Cardiac arrest 18(1.1) 0.06(0.03-0.08) 2(0.5) 0.03(0-0.08)
Status epilepticus 7(0.4) 0.02(0.01-0.04) 2(0.5) 0.03(0-0.08)
Coma 0(0) 0(0-0) 0(0) 0(0-0)
Total women affected 1612 5.07(4.82-5.32) 406 6.46(5.85-7.12)
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methodology in order to capture and audit 
these cases of PE more accurately, however, 
it is proving difficult to achieve. Hospital In-
Patient Enquiry (HIPE) data are also being 
reviewed. The NPEC has commenced a case 
assessment audit of PE in maternity units 
in 2017 in place of the Confidential Audit on 
Critical Care in Obstetrics.
To allow for direct comparison with findings 
from the Scottish Confidential Audit of Severe 
Maternal Morbidity (SCASMM), the NPEC 
adapted their methodology of using two 
management proxies (admission to ICU/CCU 
and Interventional Radiology) to identify women 
at high risk of severe morbidity. It is important 
to note that the use of Interventional Radiology 
(IR) is a procedure performed to prevent 
bleeding in women at high risk of MOH. Further, 
as very few hospitals have the resources 
to provide IR, the frequency of IR cannot be 
considered as being nationally represented. In 
this audit, the reported incidence of IR is low at 
0.08 per 1,000 maternities.
The incidence of MOH was 3.39 per 1,000 
maternities in 2016. The equivalent incidence 
of MOH for the most recent year with available 
data in Scotland (2012) was 5.8 per 1,000 
maternities (95% CI=5.2-6.5), 71% higher than 
the Irish rate. 17
The national audit in Scotland showed that their 
increasing incidence of SMM over a decade 
was due to an increase in the incidence of 
MOH. The NPEC previously showed that Ireland 
experienced an increasing trend in postpartum 
haemorrhage during 1999 to 2009.18
Figure 1 illustrates the trend in the rate of SMM 
as defined in this audit and the separate trends 
for MOH and ICU/CCU admission. An increasing 
number of MOH cases has been reported to this 
audit over the six-year period 2011-2016 (Table 
2; Figure 1).
The incidence of MOH cases increased from 
2.34 per 1,000 maternities in 2011 to 3.39 per 
1,000 maternities in 2016, an overall increase 
of 45% (rate ratio=1.45, 95% CI=1.18-1.77, 
p-value<0.001), which is highly statistically 
significant.
Major obstetric haemorrhage 
Figure 1: Trend in the rate of severe maternal morbidity (SMM), major obstetric haemorrhage 






























17 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx  
18 Lutomski J et al. (2012) Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based 
cohort study. BJOG; 119: 306-14.
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Table 3: Case criteria for major obstetric haemorrhage (MOH) in 2016
Total MOH cases N=215
Met one criterion 122(57.3)
Estimated blood loss ≥ 2500ml 97(79.5)
Received blood products as treatment for coagulopathy 23(18.9)
Transfused ≥ 5 units of blood 2(1.6)
Met two criteria 57(26.8)
Blood loss ≥ 2500ml and received blood products  
for coagulopathy
43(75.4)
Blood loss ≥ 2500ml and transfused ≥ 5 units of blood 12(21.1)
Received blood products for coagulopathy and  
transfused ≥ 5 units of blood
2(3.5)
Met all three criteria 34(16)
Note: Values are shown as n(%) unless otherwise stated; Information on MOH criteria missing on one case.
There were 27 reported cases of peripartum 
hysterectomy (PH) in 2016 giving a national 
PH rate of 0.43 per 1,000 maternities or 
approximately one in 2,300 maternities. While 
the rate in 2016 was one third higher than 
in 2011-2015 (rate ratio=1.34, 95% CI=0.88-
2.05, p-value<0.001), it was still within the 
range that might be expected considering the 
number and relative rarity of PH. Ireland’s PH 
rate has been consistent for a number of years, 
at approximately 0.33 per 1,000 births, and is 
similar to the rate in the United Kingdom (0.41 
per 1,000 births) and the Netherlands (0.33 
per 1,000 births).19,20
Major obstetric haemorrhage, as defined 
in this audit, was associated with over half 
the cases of PH (n= 16, 59.3%). Abnormal 
placentation, primarily morbidly adherent 
placenta, was the most commonly reported 
indication for PH (20/27, 74.1%), followed 
by MOH (5/27, 18.5%). Cervical cancer and 
postnatal sepsis/necrosis were the reported 
indication for PH for the other two cases. All 
but one of the 27 PH cases (96.3%) involved 
caesarean section delivery (CS) and the vast 
majority of the women had a previous CS 
(n=21, 77.8%). These findings are similar to 
that of a recent Irish study on PH. 21
Peripartum hysterectomy
19 Knight M, Kurinczuk JJ, Spark P and Brocklehurst P. United Kingdom Obstetric Surveillance System Steering Committee. 
Caesarean delivery and peripartum hysterectomy, Obstet Gynecol 2008; 111 January (1); 97-105
20 Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum hysterectomy:a prospective study in The Netherlands. Eur 
J Obstet Gynecol Reprod Biol 2006;124(2):187–92
21 Campbell, Sarah M. et al. Peripartum hysterectomy incidence, risk factors and clinical characteristics in Ireland. Eur J Obstet 
Gynecol Reprod Biol 2016, Volume 207 , 56 - 61
Over half of the MOH cases (57.3%) recorded 
in this audit met only one of the case criteria 
for major obstetric haemorrhage (57.3%; Table 
3), usually the one related to estimated blood 
loss ≥ 2,500 mls. Some 27% met two criteria 
and most of these cases involved an estimated 
blood loss exceeding 2,500ml. In a further one 
in six cases (16%), all three criteria were met. 
Two cases met the sole criterion of receiving 
a blood transfusion of at least five units and 
a further twelve women met the transfusion 
criteria in addition to experiencing a blood loss 
of at least 2,500ml (Table 3). For these women 
there was no reported receipt of coagulation 
factors. These criteria all suggest significant 
bleeding, which suggests the need to review 
the definition for MOH.
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Table 4: Specific severe maternal morbidities (SMMs) in women admitted to an intensive care 
unit or coronary care unit (ICU/CCU) in Ireland, 2016
n(%)
Total women admitted to ICU/CCU 160(100)
Major obstetric haemorrhage 61(38.1)
Septicaemic shock 13(8.1)
Peripartum hysterectomy 13(8.1)
Renal or liver dysfunction 7(4.4)











None of the above** 55(34.4)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of women admitted to ICU/
CCU in 2016. More than one morbidity may apply per woman; **women admitted to ICU due to other morbidities or other issues not 
listed.
Just over one third of the women admitted 
into an ICU/CCU in 2016 had not experienced 
a severe morbidity as defined in this audit 
(34.4%, n=55 of 160). This shows a reduction 
in the occurrence of this phenomenon 
(recording 46% in 2015) which had shown a 
steady increase over the early years of the 
audit (Figure 2). It must be acknowledged that 
admission to ICU/CCU in cases not meeting the 
criterion of a SMM as defined in this audit does 
not imply inappropriate use of ICU/CCU facilities 
but suggests the requirement of a higher level 
of observation or maternal care.
These cases, requiring a higher level of 
observation (Level 1 or Level 2 Care) related 
to issues following maternal complications 
including post partum haemorrhage (PPH) with 
a blood loss < 2,500 mls, which affected one in 
four women (n=14, 25.5%) and hypertensive 
disorders which were experienced in a further 
25.5% (n=14) of women. Twenty percent 
of these ICU admissions reported sepsis 
(n=11 ,20%) of which the majority (n=7, 
63.6%) were due to respiratory infections. A 
further six (10.9%) cases were attributed to 
cardiac complications / monitoring and the 
remaining cases were due to other obstetric 
complications.
The incidence of maternity admissions into an 
ICU/CCU has been increasing in recent years 
and reached 3.02 per 1,000 in 2015 (Figure 1). 
The rate decreased by 15% to 2.54 per 1,000 
in 2016. Table 4 details the specific SMMs 
involved in the 160 cases admitted into an ICU/
CCU. Over one in three of these cases involved 
MOH (38.1%), 8.1% involved septic shock and 
a similar proportion related to peripartum 
hysterectomy. Fourteen cases (8.8%) involved 
acute respiratory dysfunction and nine cases 
(5.6%) involved pulmonary embolism. 
Admission to ICU/CCU
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Figure 2: Proportion of cases admitted to ICU not experiencing a severe morbidity as defined in 
this audit, 2011-2016
The vast majority of ICU admissions with no 
other reported morbidity as defined in this audit 
(n=50, 90.1%) occurred in small maternity 
units. Fifty percent of these cases occurred in 
two small units with on-site ICU facilities but 
without obstetric high dependency facilities. 
Feedback from these units indicated that the 
rate of such ICU/CCU admissions reflected 
resource issues in cases where women 
required a higher level of monitoring. In 
these two units, more than half of the 25 ICU 
admissions with no other SMM as defined in 
this audit required Level 1 Care (n=16, 64.0%). 
Only one of these 25 cases required Level 3 
Care and the remaining nine cases required 
Level 2 Care (43.6%).
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22 Robson M et al. The 10-Group Classification System (Robson classification), induction of labor, and cesarean delivery. 
International Journal of Gynecology and Obstetrics 131 (2015) S23–S27 
23 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122. 
The Robson Ten Group Classification System 
(TGCS), is a method providing a common 
starting point for further detailed analysis 
within which all perinatal outcomes can 
be measured and compared.22 The system 
classifies all pregnant women into one of 10 
categories that are mutually exclusive and, as 
a set, totally comprehensive (see Appendix 
K).23 The categories are based on five basic 
obstetric characteristics that are routinely 
collected for all maternities: parity, gestational 
age, onset of labour, foetal presentation and 
number of foetuses.
Thirteen of the 19 maternity units that 
participated in the SMM audit also classified 
their maternities according to the Robson Ten 
Group Classification System (Appendix K). The 
50,296 maternities in these units accounted 
for 80.0% of the 62,871 maternities in all 19 
maternity units. The incidence of MOH and of 
other SMM, excluding cases of MOH and cases 
admitted to ICU/CCU only, in the thirteen 
maternity units that submitted Robson TGCS 
data is detailed in Table 5.
For the thirteen units, the MOH rate was 
3.36 per 1,000 maternities and the rate of 
other SMM was 2.07 per 1,000 maternities. 
Notwithstanding the relatively small numbers 
involved when examining by TGCS, there was 
evidence of increased risk of MOH in Group 8 
(women with multiple pregnancies) and in 
Group 10 (women with premature deliveries) 
and evidence of increased risk of other SMM 
in Group 10.
Robson Ten Group Classification System (TGCS)
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
 27
Note: Rates per 1,000. CI=95% confidence interval. Poisson 95% confidence intervals were calculated. CS=Caesarean section; *Other SMM excludes cases of MOH 
and cases of ICU admission only; Robson Group could not be determined for 12 MOH cases and 14 cases of other SMM.
Table 5: Incidence of major obstetric haemorrhage (MOH) and severe maternal morbidity (SMM) excluding MOH by 
Robson TGCS in thirteen Irish maternity units, 2016
Group Group description Deliveries Delivered 
by CS
MOH Other SMM*
N % n Rate  
95% CI
n Rate  
95% CI
All 50,296 31.6 169 3.36(2.87-3.91) 104
2.07
(1.69-2.51)











Multiparous (excluding previous 
CS), singleton, cephalic, >37/40, 
spontaneous labour




Multiparous (excluding previous CS), 
singleton, cephalic, >37/40 induced 
or elective CS
7,823 14.8 25 3.20(2.07-4.72) 12
1.53
(0.79-2.68)





















All women with a single pregnancy 
with a transverse or oblique lie, 
including women with previous uterine 
scars
162 100.0 1 6.17(0.16-34.39) 2
12.35
(1.50-44.60)





• Robust clinical audit on adverse 
maternal outcomes requires the 
protected time of clinical staff. Funding 
should be provided by the Health Service 
Executive (HSE) to facilitate same.
• To enhance the scope of audit, a 
national standardised approach to 
obtaining consent for processing data 
from services users would be beneficial. 
Recommendation:
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Figure 3: Funnel plot of the rate of severe maternal morbidity (SMM) by maternity unit, 2016
Variation in the 2016 SMM rate across the 
participating nineteen maternity units is 
illustrated in the funnel plot in Figure 3. The 
solid line represents the national SMM rate of 
6.46 per 1,000 maternities. The dashed curves 
represent the limits within which 95% of units 
are expected to lie (i.e. within two standard 
deviations). The solid curves represent the 
limits within which 99.8% of units are expected 
to lie (i.e. within three standard deviations). 
These limits are adjusted according to the 
number of maternities at each unit and are 
wider for smaller units reflecting the greater 
volatility in rates based on small numbers. 
In regards to the 95% confidence limits, we 
can expect, on average, one in twenty units 
to have a rate outside the dashed lines. 
However, differences between units must 
be interpreted with caution as they may not 
reflect care given but could reflect differences 
in levels of reporting and/or differences in the 
risk profile of the pregnant women presenting 
to the units.
Variation in rates by maternity unit
From Figure 3, it can be seen that three units 
have an SMM rate above the 95% upper limit 
and two units have an SMM rate above the 
99.8% upper limit. The rate for these two 
outlying units is approximately 2.5 times the 
national rate (17.59 and 15.74 vs. 6.46 per 
1,000 maternities).
A high proportion of the SMM cases for the 
unit with the highest rate (n=11 of 26, 
42.3%) were reported because they met 
the SMM criterion of being admitted to an 
ICU/CCU with no other SMM experienced 
as defined in this audit. Feedback from 
this unit identified that these were cases 
requiring monitoring above normal ward 
standard and due to low levels of staff in 
the unit, this could only be achieved by 
admission to the ICU.
It can also be seen from Figure 3 that two of 
the country’s maternity units had an SMM rate 
just below the lower 95% limit (2.64 and 3.65 
vs. 6.46 per 1,000 maternities).
The funnel plot in Figure 4 illustrates the 
variation in the SMM rate by maternity unit 
after exclusion of 57 cases admitted to an 
ICU/CCU with no other SMM experienced as 
defined in this audit. The adjusted national 
SMM rate was 5.55 per 1,000 maternities. The 
plot shows that two units had an SMM rate 
above the 95% upper limit but not above the 
99.8% upper limit.
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Figure 4: Funnel plot of the rate of severe maternal morbidity (SMM) by maternity unit excluding 
cases admitted to an ICU/CCU with no other SMM experienced as defined in this audit, 2016


























Unit SMM rate National SMM rate 95%  Limits 99.8% Limits
Figure 5 illustrates variation in the rate of MOH 
across the country’s nineteen maternity units 
in 2016. One unit had a rate above the 95% 
upper limit for the national rate of 3.39 per 
1,000 maternities but the rate was not above 
the 99.8% upper limit.
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Figure 6: Funnel plot of the rate of major obstetric haemorrhage (MOH) in 2016 and its variation 
for each maternity unit for the years 2011-2016
Figure 6 is identical to Figure 5 in that it 
illustrates the rate of MOH in Irish maternity 
units in 2016. However, in Figure 6 we have 
added error bars to illustrate the range of the 
annual MOH rate observed in each unit since 
2011. Considering this six-year period, most 
of the units with over 2,000 births had their 
highest or nearly highest MOH rate in 2016. 
The expected greater volatility in the MOH rate 
in smaller units is evident.
Variances in rates of MOH between units may 
reflect variances in practices of estimating 
blood loss.  We have reflected on methods 
of estimating blood loss in units with high 
and low rates of MOH and observed a lack of 
standardisation.
We have previously recommended that a 
quantitative approach involving volume and 
weight assessment to estimate blood loss 
be considered for use in all maternity units 
and that development of a national tool-kit 
would assist standardisation of such an 
approach. These recommendations are being 
addressed by the National Women and Infant 
Health Programme. While no one tool may be 
completely accurate in estimating blood loss, a 
standard quantitative approach should facilitate 
a less variable assessment of blood loss.
Note: The error bars illustrate the variation in each unit’s annual MOH rate since 2011
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
 31
 Age group SMM SMM SMM SMM  All maternities SMM rate Rate ratio
  2013 2014* 2015* 2016* 20161 2016 (95% CI)
  (N=319) (N=363) (N=371) (N=405)  (95% CI)
 <20yrs 6(1.9) 5(1.4) 3(0.8) 7(1.7) 1.7% 6.38 1.37
       (2.56-13.14) (0.59-3.18)
 20-24yrs 20(6.2) 33(9.1) 34(9.2) 24(5.9) 8.2% 4.65 Ref.
       (2.98-6.92) 
 25-29yrs 44(13.6) 57(15.7) 66(17.8) 63(15.6) 17.9% 5.59 1.20
       (4.29-7.15) (0.75-1.92)
 30-34yrs 118(36.5) 126(34.7) 117(31.5) 141(34.8) 36.1% 6.22 1.34
       (5.24-7.34) (0.87-2.06)
 35-39yrs 100(31.0) 110(30.3) 117(31.5) 134(33.1) 29.3% 7.28 1.57
       (6.1-8.63) (1.01-2.42)
 ≥40yrs 35(10.8) 32(8.8) 34(9.2) 36(8.9) 6.8% 8.44 1.82
       (5.91-11.69) (1.08-3.04)
Note: Values are shown as n(%) unless otherwise stated. Data for all maternities are from Perinatal Statistics Report 2016. 1Healthcare Pricing Office (HPO). 
Dublin: HPO, 2018. SMM rate per 1,000 births. * Maternal age was not known for two women in 2014, one woman in 2015 and 2016. Poisson 95% confidence 
intervals were calculated for the rare ratios.
Table 6: Age distribution of women who experienced severe maternal morbidity (SMM), 2013-2016
Age
Maternal age, was recorded for 405 of the 406 
cases of severe maternal morbidity (SMM) 
in 2016 and ranged from 16 to 51 years. The 
mean age was 33.0 years (standard deviation 
= 5.5 years). The age distribution of women 
who experienced SMM in 2013-2016 is 
detailed in Table 6. In 2016, 68% were aged 30-
39 years which was similar to the population 
of women who gave birth in 2016 (65.4%). 
Women aged 35 years or over were somewhat 
overrepresented: they accounted for 42.0% 
of SMM cases in 2016 compared to 36.1% 
of the population who gave birth that year. 
This is reflected in the SMM rate calculated 
by maternal age based on data for 2016 
(Table 6), whereby the highest SMM rate was 
among 35-39 year-olds and women over 40 
years of age.
Maternal characteristics
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Ethnicity
There are no national data available on 
ethnicity for the pregnant population in 
Ireland. The distribution by ethnic group of the 
women who experienced SMM in 2016 broadly 
reflected that of the general population of 
women aged 15-49 years as reported from 
the most proximal national census (Table 7).24 
In those who experienced SMM there was a 
slight overrepresentation of women whose 
ethnicity was described as Black as they 
made up 5.2% of SMM cases compared to 
1.6% of the population aged 15-49 years in 
this ethic group. Similarly, women of Asian 
and Irish traveller ethnicity were over-
represented in experiencing SMM when 
compared to the percentage of females aged 
15-49 years of those ethnicities in the Irish 
population.
 SMM 15-49 year-old
 2016 female population, 20161
 (N=406) % 
White Irish 301(74.1) 77.1
Irish Traveller 6(1.5) 0.7
Other white background 44(10.8) 13.3
Asian/Asian Irish 23(5.7) 2.7
Black/Black Irish 21(5.2) 1.6
Other/mixed 3(0.7) 1.8
Not recorded 8(2) 2.7
Note: Values are shown as n(%) unless otherwise stated. 1 Central Statistics Office. (2018). Census 2016.
Table 7: Ethnicity of women who experienced severe maternal morbidity (SMM), 2016
24 Central Statistics Office. (2018). Census 2016.
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BMI category (kgm-2) SMM SMM Healthy Ireland
 2015 2016 Survey 2015
 (N=335)* (N=372)* % 
Underweight (<18.5) 5(1.5) 7(1.9) 3
Healthy (18.5-24.9) 156(46.6) 144(38.7) 44
Overweight (25.0-29.9) 100(29.9) 135(36.3) 31
Obese (≥30.0) 74(22.1) 86(23.1) 22
Note: Values are shown as n(%) unless otherwise stated. * BMI was not known for 37 women in 2015 and 34 women in 2016.
Table 8: Body mass index (BMI) of women who experienced severe maternal morbidity (SMM), 2016
Body mass index
Body mass index (BMI) for the women who 
experienced SMM in 2016 ranged from 16.4 to 
55.4kgm-2. BMI was not known for 34 (8.4%) of the 
women. This represents a marginal improvement 
in the level of reporting of BMI (91.6%) when 
compared with SMM cases in 2015 (90.1%).
Over one third of the women who experienced 
SMM in 2016 had a BMI in the healthy range 
(38.7%), 36.3% were overweight and 23.1% were 
obese (Table 8). In comparison to 2015 SMM 
data, this represented a noticeable increase in 
the proportion of women experiencing a SMM 
who were in the overweight category (from 29.9% 
in 2015 to 36.3 % in 2016) with a corresponding 
reduction in women in the healthy category (from 
46.6% in 2015 to 38.7% in 2016). It was also 
observed that of the total of women experiencing 
two SMMs or three SMMs in 2016, a higher 
proportion were categorised as overweight or 
obese (69.6% of women and 57.1% respectively).
There are no national data available on BMI for the 
pregnant population in Ireland. The BMI profile in 
this 2016 audit is similar to that of the women 
in the 2015 Healthy Ireland Survey.25 However, 
interpretation of this comparison must consider 
the weight gain due to pregnancy for the women 
who experienced SMM as the Healthy Ireland 
Survey was of the general population.
25  Ipsos MRBI (2015). Healthy Ireland Survey 2015. Dublin: The Stationery Office.
26 Knight M, UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 2008; 115 (4):453-461
27 Malinowski AK, Bomba-Opoñ D et al. Venous thromboembolism in obese pregnant women: approach to diagnosis and 
management.  Polish Gynaecology 2017; vol. 88, Issue 8: 453–459 
28 Beckett VA, Knight M, Sharpe P. The CAPS Study: incidence, management and outcomes of cardiac arrest in pregnancy in the 
UK: a prospective, descriptive study. BJOG; 2017, vol 124, Issue 9: 1374-1381
Table 9 details the percentage of women 
experiencing specific morbidities who were 
categorised as either overweight or obese. 
As previously mentioned, 60% of women 
who experienced a morbidity had a high BMI 
(36.3% overweight and 23.1% obese). High 
BMI has been associated with maternal 
mortality and morbidity, in particular 
morbidities such as pulmonary embolism 
and complications of anaesthetics.26,27,28 
As shown in Table 9, among those who 
had specific maternal morbidities, 
women with high BMI were largely over-
represented in the group of those affected 
by anaesthetic problems, cerebrovascular 
events, pulmonary oedema and pulmonary 
embolism.
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High BMI = BMI in the category overweight (25.0-29.9) and obese (≥30.0); Lower BMI = BMI in the category underweight (<18.5) 
or healthy (18.5-24.9)
Table 9: Proportion of women with higher Body mass index (BMI) who experienced severe 
maternal morbidity (SMM), 2016
Morbidity Women with high BMI Women with lower BMI
n(%) n(%)
Major obstetric haemorrhage 115(59) 80(41)
Pulmonary oedema 10(83.3) 2(16.7)
Pulmonary embolism 18(78.3) 5(21.7)
Acute respiratory dysfunction 8(72.7) 3(27.3)
Anaesthetic problem 5(100) --
Cerebrovascular event 4(100) --
Smoking, alcohol and drug misuse
Smoking status at the time of the first hospital 
booking appointment was known for 91.4% 
of the 406 women. Of these, 8.6 % (n=32 of 
371) were reported to have been smoking at 
the time of the first booking. The prevalence 
of smoking during pregnancy is not routinely 
published for all Irish pregnancies but rates 
of 12%, 15%, 16% and 19% have been reported 
for England, Northern Ireland, Wales and 
Scotland, respectively.29
The quantity smoked was recorded for 26 of 
the 32 women who were smokers at the time 
of the first hospital booking appointment. 
Most commonly, these women smoked 5 or 
 
10 cigarettes per day (range: 3-30). Of these 
26 women, six were reported to have given up 
smoking during pregnancy (n=6 of 26, 23.1%, 
unknown for six cases of women smoking).
Alcohol drinking status at the time of the first 
hospital booking appointment was not known 
for 16.7% of the women (n=68). Of the 338 
women with available data, only 2.7% were 
reported to be drinking alcohol (n=9).
Five women were recorded as having a 
documented history of drug abuse or 
attendance at a drug rehabilitation unit (1.3%, 
n=5 of 398, unknown for eight cases).
• Maternal and Newborn Clinical Management System (MN_CMS) data from Irish 
maternity units should be collated to identify the influence of risk factors for SMM in 
Ireland including: ethnicity, maternal age, BMI, smoking and employment status.
Recommendation:
29 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
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Previous pregnancy 
Forty five percent (45.4%) of the women who 
experienced a SMM in 2016 were nulliparous 
which is similar with previous years 
(Table 10). Women without any previous 
completed pregnancies (nulliparous) were 
over-represented in the group of individuals 
experiencing SMM, when comparing with 
all the maternities in Ireland for the same 
year. Conversely, women who had had one 
previous completed pregnancy, i.e. para 
1, were underrepresented among the SMM 
cases when compared with the population 
of women birthing in Ireland in 2016 (26.8% 
versus 35.0%). 
 
This is reflected in the SMM rate, which was 
lowest for para 1 women at 4.91 per 1,000 
maternities. The SMM rate for women who 
had more than one previous completed 
pregnancy, i.e. para 2 and para 3+, was 
similar to the overall national rate of 6.46 
per 1,000. However, the SMM rate for these 
women was 30-40% higher than for para 1 
women. Nulliparous women had the highest 
SMM rate at 7.66 per 1,000, 56% higher than 
the rate for para 1 women.
Previous early pregnancy loss was reported for 
nearly one third of the women who experienced 
SMM in 2016 (31.3%, 126 of 402; unknown 
for four women). Seventeen women (4.2%) 
had previously experienced three or more 
pregnancies that ended before 24 weeks 
gestation.
Table 10: Distribution of parity for women who experienced severe maternal morbidity (SMM), 2013-2016
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for two, six, one and three cases in 2013, 2014, 2015 and 2016, respectively. Data 





















Nulliparous 122(38.0) 152(42.3) 152(41.0) 183(45.4) 38.0% 7.66 (6.59-8.85)
1.56 
(1.23-1.98)
Para 1 97(30.2) 101(28.1) 107(28.8) 108(26.8) 35.0% 4.91 (4.03-5.93) (Ref.)
Para 2 55(17.1) 67(18.7) 65(17.5) 73(18.1) 18.0% 6.46 (5.06-8.12)
1.31 
(0.98-1.77)
Para 3+ 47(14.6) 39(10.9) 47(12.7) 39(9.7) 9.1% 6.84 (4.87-9.36)
1.39 
(0.97-2.01)
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For 10% of the women who experienced SMM 
in 2016, their pregnancy was the result of 
infertility treatment (n=42 of 405, 10.4%; 
unknown for one woman). In nearly three 
quarters of these cases the method of 
infertility treatment was in vitro fertilisation 
(n=31, 73.8%). 
The prevalence of a previous caesarean 
section was over 45% among the women 
who had previously given birth (n=97 of 217, 
44.7%; not known for eight women.
 
 
Gestation at delivery or pregnancy end for 
women who experienced a SMM ranged from 
five to 42 weeks. For over two thirds of the 
women affected (67.9%), their pregnancy 
went full term (Table 11). For a further 20.8%, 
their pregnancy ended at moderate-to-late 
pre-term gestation (32-36 weeks). For 4% of 
the women, the end of pregnancy occurred 
before 22 weeks gestation.
Early pregnancy loss (i.e. delivered before 24 
weeks gestation and birthweight less than 
500g) was experienced by 18 of the 404 
women (4.5%, unknown for two cases). These 
involved 11 cases of miscarriage (2.7%) and 
seven cases of ectopic pregnancy (1.7%). 
Thirteen of the early pregnancy loss cases 
were diagnosed with one SMM (eight cases 
of miscarriage and five cases of ectopic 
pregnancy) and four cases were diagnosed 
with two SMMs (two cases of miscarriage 
and two cases of ectopic pregnancy). One 
additional case of miscarriage was diagnosed 
with three SMMs. 
 
 
Major Obstetric Haemorrhage was the most 
frequently reported SMM associated with 
twelve cases of early pregnancy loss (six 
miscarriages and six ectopic pregnancies). 
There were four cases with admission to 
ICU/CCU of which one was associated with 
miscarriage and the remaining related to 
ectopic pregnancies. Septicaemic shock was 
reported in four cases, all associated with 
miscarriage. Other reported SMMs in the 
early pregnancy loss cases included uterine 
rupture (n=3) and pulmonary embolism 
(n=1).
 2013 2014 2015 2016
 (N=317)* (N=348)* (N=367)* (N=399)*
Pre-viable (<22wks) 11(3.5) 14(4.0) 20(5.4) 16(4)
Extremely pre-term (22-27wks) 15(4.7) 14(4.0) 14(3.8) 9(2.3)
Very pre-term (28-31wks) 14(4.4) 19(5.4) 25(6.8) 18(4.5)
Moderate/late pre-term (32-36wks) 73(23.0) 78(22.3) 63(17.2) 83(20.8)
Term (37-41wks) 204(64.4) 224(64.0) 241(65.7) 271(67.9)
Post-term (42wks+) 0(0.0) 1(0.3) 4(1.1) 2(0.5)
Table 11: Gestation at delivery or pregnancy end for women who experienced severe maternal morbidity, 2013-2016
Note: Values are shown as n(%) unless otherwise stated; * Gestation was not known for six ,15, five and seven cases in 2013, 2014, 2015 and 2016 respectively.
Obstetric factors associated with the severe maternal morbidity event
Severe maternal morbidity associated with early pregnancy loss
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 SMM SMM SMM SMM All SMM rate Rate ratio
 2013 2014 2015 2016 maternities (95% CI) (95% CI)
 (N=323) (N=338)* (N=351)* (N=385)* 2016 
Single 296(91.6) 314(92.9) 328(93.4) 356(92.5) 98.1% 5.77 1.00
      (5.19–6.41) (Ref.)
Multiple 27(8.4) 24(7.1) 23(6.6) 29(7.5) 1.9% 23.85 4.13
      (16.0-34.25) (2.83-6.03)
Table 12: Single and multiple birth for women who experienced severe maternal morbidity (SMM) but who did not 
experience early pregnancy loss, 2013-2016
Note: Data for all maternities are from Perinatal Statistics Report 2017. Healthcare Pricing Office (HPO). Dublin: HPO, 2017 (in press). Values are shown 
as n(%) unless otherwise stated. SMM rate per 1,000 births. *Not known for nine women in 2014, two cases in 2015 and one case in 2016. Poisson 95% 
confidence intervals were calculated for the rate ratios.
A total of 386 women had an SMM which 
was not associated with early pregnancy 
loss (unknown for one case). As shown 
in Table 12, among these women 29 had a 
multiple birth (n=29 of 385, 7.5%; single/
multiple birth not known for one woman). 
Twenty-eight of the multiple births involved 
twins and one involved quadruplets. In 
Ireland in 2016, multiple births made up 
1.9% of all maternities (n=1,216 of 62,871). 
Thus, multiple pregnancy was four times 
more common in cases of SMM than in all 
maternities, a reflection of the increased risk 
of SMM associated with multiple pregnancy. 
 
 
This is evident from the national SMM rate of 
5.77 per 1,000 maternities associated with 
singleton pregnancy in 2016 and a 4 times 
higher rate of 23.85 per 1,000 maternities for 
multiple pregnancy (p-value<0.001).
These findings are similar to the most 
recent reports from Scotland where 6.4% of 
SMM cases with available data in 2012 were 
associated with twin pregnancies, four times 
higher than their proportion of twin births in 
2012 (1.5%).30
30 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
Severe maternal morbidity associated with multiple pregnancy
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Mode of delivery
The mode of delivery for two thirds of 
the 386 (three cases unknown) women 
whose SMM was not associated with early 
pregnancy loss in 2016 was caesarean 
section (Table 13). This is over twice the 
32.6% caesarean section rate occurring 
in all births nationally in 2016.31 The 
majority of caesarean sections in cases of 
SMM were carried out prior to labour which 
may reflect the clinical complexity of the 
pregnancy rather than mode of delivery 
influencing risk of SMM. Over one in three 
women had a vaginal delivery (36%), usually 
spontaneously (23.5%).
  2013 2014 2015 2016
  (N=309)* (N=337)* (N=349)* (N=383)*
Vaginal 102(33.0) 114(33.8) 124(35.5) 138(36)
 Spontaneous 73(23.6) 67(19.9) 73(20.9) 90(23.5)
 Assisted breech 3(1.0) - 7(2.0) 0(0)
 Ventouse 16(5.2) 25(7.4) 29(8.3) 30(7.8)
 Non-rotational forceps 10(3.2) 18(5.3) 15(4.3) 14(3.7)
 Rotational forceps - 4(1.2) - 4(1)
Caesarean section 207(67.0) 223(66.2) 225(64.5) 245(64)
 Elective LSCS (no labour) 59(19.1) 54(16.0) 63(18.1) 55(14.4)
 Emergency LSCS (no labour) 77(24.9) 99(29.4) 79(22.6) 101(26.4) 
 Elective LSCS (labour) 5(1.6) 7(2.1) 3(0.9) 7(1.8)
 Emergency LSCS (labour) 63(20.4) 61(18.1) 79(22.6) 81(21.1)
 Classical 3(1.0) 25(7.4) 1(0.3) 1(0.3)
Note: Values shown are n(%) unless otherwise stated; * Mode of delivery was not known for two, ten, two and three cases in 2013, 2014, 2015 and 
2016, respectively. For cases of multiple birth when mode of delivery differed for the babies, the more complex mode of delivery was taken as the 
primary mode. LSCS=Lower segment caesarean section. Data excludes 12, 18, 19 and 18 cases of early pregnancy loss in 2013, 2014, 2015 and 
2016 respectively.
Table 13: Primary mode of delivery (excluding those who experienced early pregnancy loss) for women who 
experienced severe maternal morbidity, 2013-2016
31  Healthcare Pricing Office. (2018) Perinatal Statistics Report 2016. Dublin: Health Service Executive. [in press]
• A public health education programme on maternal morbidity and modifiable risk 
factors should be developed.
Recommendation
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
 39
Maternal care details
The level of maternal care provided has been 
recorded since the 2014 SMM audit. Virtually 
all of the women who experience SMM in 
2016 required an increased level of support/ 
critical care (Table 14). Almost half required 
Level 1 Care (44.8%), 47.3% required Level 2 
Care and 6.9% required Level 3 Care.
Only approximately one in six of the women 
admitted to an ICU/CCU required Level 3 Care 
(17.5%); almost half of women admitted to 
ICU/CCU required Level 2 Care and 33.8% 
required Level 1 Care (Table 15). This 
highlights that admission to an ICU/CCU does 
not infer that a woman has a requirement for 
Level 3 Care. Half of the 54 women admitted 
to an ICU/CCU requiring Level 1 Care only did 
not experience another SMM as defined by 
this audit (n=27, 50%).
Table 14: Level of maternal care provided to 406 women during clinical SMM events in Ireland, 2016
Level of Care Definition N(%)
Level 0:
Normal ward care
Care of low risk pregnant women 4(1)
Level 1:
Additional monitoring or 
intervention, or step down 
from higher level of care
Patients at risk of their condition deteriorating and 
needing a higher level of observation or those recently 




Patients requiring invasive monitoring/ intervention 
including support for a single failing organ system (incl. 





support alone, or support of 
two or more organ systems
Patients requiring advanced respiratory support 
(mechanical ventilation) alone or basic respiratory 
support along with support of at least one additional 
organ
28(6.9)
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Note: % shown refers to level of care per each type of morbidity; ICU=intensive care unit; more than one morbidity may apply per woman. 









Total of women 406(100) 4(1) 182(44.8) 192(47.3) 28(6.9)
Major obstetric haemorrhage 215(53) 1(0.5) 113(52.6) 88(40.9) 13(6)
ICU/coronary care unit admission 160(39.4) - 54(33.8) 78(48.8) 28(17.5)
Renal or liver dysfunction 34(8.4) - 5(14.7) 27(79.4) 2(5.9)
Septicaemic shock 28(6.9) - 7(25) 19(67.9) 2(7.1)
Peripartum hysterectomy 27(6.7) - 8(29.6) 15(55.6) 4(14.8)
Pulmonary embolism 24(5.9) 2(8.3) 12(50) 8(33.3) 2(8.3)
Uterine rupture 8(2) 1(12.5) 1(12.5) 6(75) -
Pulmonary oedema 12(3) - 4(33.3) 6(50) 2(16.7)
Eclampsia 14(3.4) - 2(14.3) 11(78.6) 1(7.1)
Interventional radiology 5(1.2) - - 5(100) -
Acute respiratory dysfunction 14(3.4) - - - 14(100)
Cerebrovascular event 4(1) - 1(25) 2(50) 1(25)
Status epilepticus 2(0.5) - 1(50) 1(50) -
Cardiac arrest 2(0.5) - 1(50) - 1(50)
Anaesthetic problem 5(1.2) - 2(0) 1(0) 2(0)
For Major Obstetric Haemorrhage, the majority 
of cases required Level 1 Care (52.6%) while 
40.9% required Level 2 Care and 6% required 
Level 3 Care. As expected clinically, higher 
levels of critical care/monitoring were 
required for the women experiencing life-
threatening maternal morbidities, e.g. acute 
respiratory dysfunction and cardiac arrest.
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Neonatal outcomes
Of the 386 women whose SMM was not associated 
with early pregnancy loss (not known for two 
women), a total of 416 babies were delivered: 356 
singleton births, 28 twin births (56 babies) and 
one birth of quadruplets. Information on neonatal 
outcome in terms of perinatal death was available 
for 409 of these infants. Of the 409 births, there 
were 14 stillbirths, two early neonatal deaths 
and no known late neonatal deaths. Therefore, 
in total, there were 393 live born infants.
Only two of the 14 stillbirths were associated 
with a multiple pregnancy (one twin and one 
from quadruplets), whereas both of the early 
neonatal deaths were associated with singleton 
pregnancies. Gestation at delivery for these 16 
perinatal deaths occurred before 22 weeks for 
the two early neonatal death cases (12.5% of 
all perinatal deaths). For one delivery (6.3%) 
gestation was 22-27 weeks (extremely pre-
term), for two babies (12.5%) it was very pre-term 
(28-31 weeks) and seven stillbirths (43.8%) were 
delivered at late pre-term (32-36weeks). The four 
(25.0%) additional stillbirths were delivered at 
term (37-41 weeks). Over half of the 12 women 
affected by perinatal deaths (n=7, 58.8%) 
experienced major obstetric haemorrhage.
The mortality rate based on the 14 stillbirths and 
two early neonatal deaths among the 409 infants 
was 39.1 per 1,000 births, i.e. approximately 4% 
or one in 25 of the infants died. This rate was 6.7 
times the perinatal mortality rate observed for all 
births in Ireland in 2016 (p-value<0.001; Table 
16). However, the rate is in line with the perinatal 
mortality rate among infants born to women with 
SMM in Scotland in recent years, which ranged 
from 17 to 64 per 1,000 maternities. 32
32 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
Approximately 5% (n=19, 4.7%) of the 408 
live born infants were intubated following 
delivery and less than half (n=188, 46.1%) 
were transferred to the Special Baby Care 
Unit (SBCU) or Neonatal Intensive Care Unit 
(NICU; Table 17).
 N=408*
Intubation following delivery 19(4.7)
Transfer to SBCU/NICU  188(46.1)
Table 17: Selected neonatal outcomes, 2016
Note: SCBU=Special Baby Care Unit; NICU=Neonatal Intensive Care Unit.* n= total number of live births, neonatal outcome 
unknown for eight babies.
 Perinatal deaths Births PMR Rate ratio
   (95% CI)  (95% CI)
All births 2016* 374 64,133 5.8(5.3-6.5) 1.0(Ref.)
SMM 2016 16 409 39.1(22.4-63.5) 6.71(4.07-11.06)
Table 16: Perinatal mortality among infants born to women with SMM in Ireland in 2016 compared to 
perinatal mortality among all infants born in Ireland
Note: PMR=perinatal mortality rate per 1,000 births; * Manning E, Leitao S, Corcoran P, McKernan J, de Foubert P, Greene RA, on behalf of the 
Perinatal Mortality Group. Perinatal Mortality in Ireland Annual Report 2016. Cork: National Perinatal Epidemiology Centre, 2017. Poisson 95% 
confidence intervals were calculated for the rate and the rate ratios.
The findings of this national SMM audit highlight the clear need for on-going prospective 
audit in order to identify adverse maternal outcomes. Although Severe Maternal Morbidity 
may reflect the complexity of the pregnant population, it also acts as a surrogate measure 
of quality of care in the maternity services.
In summary
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This section of the report presents findings 
from the third and final year of the audit 
of critical care in obstetrics in Ireland. The 
purpose of this audit is to address the dearth 
of national data on the prevalence rates for 
women who require Level 2 and Level 3 Care 
and the location where higher levels of care 
are provided. While all Level 3 intensive care 
patients will be admitted to a Level 3 Care Unit 
and be readily identifiable in future Intensive 
Care National Audit and Research Centre 
(ICNARC) data, estimation of the requirement 
for Level 2 Care is more complicated.  Women 
requiring Level 2 Care may have all or part of 
their critical care needs met in a maternity 
unit, but at the present time there is no 
national data recording this activity. 
Fifteen of the nineteen Irish maternity 
units have contributed data to this audit 
for the years 2014 to 2016, including; two 
large tertiary referral maternity units and 
13 smaller maternity units. In the case of 
a woman requiring Level 2 or Level 3 Care, 
participating units were asked to complete 
a specific proforma (Appendix G). The main 
clinical diagnosis, organ support required and 
specialist review during the critical care event 
were documented on this form. Additional 
data on maternal demographics and neonatal 
outcomes were reported on the NPEC SMM 
notification form. 
Levels of critical care
National and International guidelines 
have recommended that the terms high 
dependency and intensive care be replaced 
by the term critical care.33,34 The term 
critical care has a more precise definition 
whilst the terms maternal critical care, 
high dependency care and high risk 
maternity care are not interchangeable. 
Figure 2.1 shows the type of unit of care 
available  in the various maternity units in 
the country.
Within the term critical care, care is 
subdivided into four levels, dependent on 
organ support and the level of monitoring 
required independent of clinical 
diagnosis. Levels of care are detailed in 
Appendix F.
Section 2. Confidential Audit of Critical Care in Obstetrics in Ireland
33 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, 
Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive
34 Royal College of Obstetricians and Gynaecologists (2011).Maternal Critical Care Working Group. Providing equity of critical and maternity 
care for the critically ill pregnant or recently pregnant woman. 
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Figure 2.1 - Map of maternity units and hospital groups in the Republic of Ireland according to type of unit of care 
available (2016)
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Overall, 370 women, out of 40,196 maternities 
cared for in the fifteen reporting units, required 
either Level 2 or Level 3 Care (Table 2.1). This 
gives a rate of 9.2 per 1,000 maternities or one 
in 109 maternities. Of these, 351 women required 
Level 2 Care only (8.73 per 1,000 maternities or 
one in 114 maternities) and 19 women required 
Level 3 Care, either solely or in combination with 
Level 2 Care, during the clinical event (0.47 per 
1,000 maternities or one in 2,127 maternities). 
Main findings
Level of Critical Care N(%) 
Level 2 Care only 351(94.9)
Level 2 followed by Level 3 Care 1(0.3)
Level 2 followed by Level 3 followed by Level 2 Care 4(1.1)
Level 3 Care only 6(1.6)
Level 3 followed by Level 2 Care 8(2.2)
Table 2.1: Sequence of critical care provided to women who required Level 2 or 3 Care, 2016
Note: The duration of Level 3 Care was unknown for two women.
Duration of critical care
The duration of care for the vast majority 
of women who required Level 2 Care only 
(88.9%), did not exceed two days (Figure 2.2). 
The maximum duration for Level 2 Care was 9 
days and 8.0% of women were provided Level 
2 Care for three to four days. Of the 19 women 
who required Level 3 Care, the maximum 
duration of Level 3 Care was 17 days (duration 
of care missing for two women). For the 
majority (70.6%) of these cases, the duration 
of Level 3 Care did not exceed four days.
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Data on pre-existing co-morbidities was 
available for 344 of the 351 women who 
required Level 2 Care only and for all the 19 
women requiring Level 3 Care. Over forty 
percent of the women needing Level 2 Care 
only had pre-existing co-morbidities (n=171, 
48.7%) and over half of the women requiring 
Level 3 Care had pre-existing co-morbidities 
(n=11, 57.9%; Figure 2.3).
The pregnancy risk level during the antenatal 
period was recorded for 322 of the 351 women 
requiring Level 2 Care only and for all the 19 
women requiring Level 3 Care. The pregnancy 
was identified as high risk in over forty percent 
of women requiring Level 2 Care only (n= 
163, 46.4%) and in 52.6% (n=10) of women 
who required Level 3 Care. This suggests that 
the need for higher levels of maternal care 
is not predictable in approximately half of 
women requiring critical care and thus has 
implications for resource planning.
Pre-existing co-morbidities and antenatal risk assessment
Figure 2.3: Pre-existing co-morbidities and antenatal risk assessment for women who required 
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 Table 2.2: Body mass index (BMI) of women who required Level 2 or Level 3 Care, 2016
Note: Values are shown as n(%) unless otherwise stated. * BMI was not known for 30 women who required Level 2 or Level 3 Care 
and 34 SMM cases. 
Maternal characteristics
Body mass index (BMI) for the women who 
required Level 2 or Level 3 Care in 2016 
ranged from 16.4 to 49.8 kgm-2. BMI was not 
known for 30 of the 370 women requiring 
these types of care. This level of BMI reporting 
is similar to that for SMM cases in the previous 
audit years. 
Just under forty percent (n=128, 37.6%) of 
these women had a BMI in the healthy range, 
34.7% (n=118) were overweight and one 
quarter of the women (25.9%, n=88) were 
obese (Table 2.2). This BMI profile closely 
matches that of all women who experienced 
SMM in 2016, as defined in the NPEC SMM 
audit, and of the general population of women 
sampled in the 2015 Healthy Ireland Survey.









Underweight (<18.5) 6(1.8%) 7(1.9%) 3
Healthy (18.5-24.9) 128(37.6%) 144(38.7%) 44
Overweight (25.0-29.9) 118(34.7%) 135(36.3%) 31
Obese (≥30.0) 88(25.9%) 86(23.1%) 22
Over half of the women who required Level 2 or 
Level 3 Care in 2016 were nulliparous (n=212, 
57.6%; Table 2.3). This is higher than was 
observed among all women who experienced 
SMM in 2016 and is also higher than in the 
population of women who gave birth in 2016, 
thus nulliparous women are over-represented 
amongst those who required Level 2 or Level 3 
Care. The number of multiparous women who 
required Level 2 or Level 3 Care was broadly 
similar to the number who experienced SMM 
in 2016 and in the case of Para 2 and Para 3+ 
women, similar to the population who gave 
birth in 2016. 
Table 2.3: Distribution of parity for women who required Level 2 or Level 3 Care, 2016
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for two women who required Level 2 or Level 
3 Care and three SMM cases. Data for all maternities are from Perinatal Statistics Report 2016. Healthcare Pricing Office (HPO). 
Dublin: HPO, 2017









Nulliparous 212(57.6%) 183(45.4%) 38.0%
Para 1 71(19.3%) 108(26.8%) 35.0%
Para 2 51(13.9%) 73(18.1%) 18.0%
Para 3+ 34(9.2%) 39(9.7%) 9.1%
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Multiple Pregnancies
Compared to the population of women who 
gave birth in 2016, there was a large over-
representation of women with multiple 
pregnancies amongst those who required 
Level 2 or Level 3 Care (Table 2.4).
Table 2.4: Single and multiple births in women who required Level 2 or Level 3 Care, 2016
Note: Data for all maternities are from Perinatal Statistics Report 2016. Healthcare Pricing Office (HPO). Dublin: HPO, 2017. 
*Single and multiple pregnancy unknown for 11 women requiring Level 2 or 3 care; **Single and multiple births in women in 
2016 whose SMM was not associated with early pregnancy loss, unknown for 3 cases (2 cases not know if early pregnancy 
loss or not and one case not known multiple/single pregnancy)









Single 323(89.7%) 356(92.5%) 98.1%
Multiple 36(10%) 29(7.5%) 1.9%
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Maternal morbidity in women requiring Level 2 Care
Maternal morbidity was classified as direct, 
indirect or coincidental based on the main 
clinical diagnosis during the critical care 
event, using the WHO classification for 
maternal mortality (Appendix H).35 Briefly 
described, direct maternal morbidities refer 
to obstetric complications of the pregnancy 
state while indirect maternal morbidities refer 
to medical complications resulting from pre-
existing disease, or disease that developed 
during pregnancy which was not the result 
of direct obstetric causes, but which was 
aggravated by the physiological effects of 
pregnancy. The majority of women (92.9%) 
requiring Level 2 Care in this critical care audit 
were classified as having a direct obstetric 
morbidity, 7.1% had an indirect morbidity 
(n=25) and there were no cases due to 
coincidental causes (Table 2.5). The main 
causes of direct obstetric morbidity in women 
who required Level 2 Care were attributable to 
hypertensive disorders (57.3%) and obstetric 
haemorrhage (25.1%). 
The absence of international consensus 
on definitions of SMM is problematic and 
impedes comparative analysis and uniform 
case-identification criteria. The WHO defines 
severe maternal complications as potentially 
life-threatening conditions and a maternal 
near miss as an event where a woman who 
nearly died but survived a complication during 
pregnancy, childbirth or within 42 days of 
termination of pregnancy.36
Table 2.5 demonstrates the number of 
maternal morbidities identified using three 
different classification systems for maternal 
morbidity: the NPEC SMM (pg. 5 of Appendix 
E), the WHO Near Miss (NM) criteria (Appendix 
I) and the WHO Severe Maternal Complication 
(SMC) criteria (Appendix J). Sixty percent 
of direct morbidities (n=130) fulfilled the 
NPEC SMM criteria, however, 17 (13.1%) 
of these cases fulfilled the criteria due to 
ICU admission only (not experiencing any 
additional morbidities included in the SMM 
audit). All of the cases with direct causes 
of SMM satisfied the WHO Severe Maternal 
Complication (SMC) criteria. However, only 
9.8% of the cases matched the WHO Near Miss 
(NM) criteria (two additional cases, 0.6%, did 
not have sufficient data to determine these 
criteria). 
Considering the NPEC SMM and WHO 
Near Miss (NM) definitions utilise organ 
dysfunction criteria, it is evident that a 
number of women requiring Level 2 Care do 
not experience organ dysfunction as their 
clinical needs were identified and treated 
before organ dysfunction occurred. This is 
similar to findings of a recent study of HDU 
admissions in a tertiary referral maternity 
unit in Ireland.37
Specific findings for women who required Level 2 Care only
35 The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM. World Health Organisation 2012
36 World Health Organisation, Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for 
maternal health. World Health Organization; 2011
37 O’Malley E, Popivanov P, Fergus A and Byrne B. Maternal Near Miss: what lies beneath? European Journal Obstetric Gynaecology 
Reproductive  Biology 2016;199
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Table 2.5: Classification of maternal morbidity in women who required Level 2 Care in 2016 according  
to the NPEC Severe Maternal Morbidity (SMM), WHO Near Miss (NM) and WHO Severe Maternal Complication (SMC).
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Coincidental -- -- -- --
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Overall, among the 351 women who received 
Level 2 Care, the most common organ 
support required was Basic Cardiovascular 
Support (BCVS; n=271, 77.2%). BCVS alone 
was provided in 38.7% of these 271 cases. 
This type of organ support was also facilitated 
in combination with neurological support, 
in 34.8% of cases, or with Basic Respiratory 
support (BRS) in 3.7% of the 271 cases (Table 
2.6).  BCVS constituted invasive monitoring, 
primarily arterial line placement, and or IV 
anti-hypertensive. 
Cases where Basic Cardiovascular Support 
(BCVS) and neurological support were 
required were also frequent (n=122, 34.8%). 
Among these cases the primary indication 
for transfusion of magnesium sulphate was 
mainly for the prophylaxis of eclampsia in 
severe pre-eclampsia (n=116, 95.1%). 
Organ support required
Table 2.6: Single organ support required during Level 2 Care, 2016
Organ support required N (%)
Basic Cardiovascular Support (BCVS) 271(77.2%)
BCVS alone 136(38.7%)
BCVS and Magnesium Sulphate Infusion (and Neurological) 122(34.8%)
BCVS and Basic Respiratory Support (BRS)* 13(3.7%)
Advanced Cardiovascular Support (ACVS) 1(0.3%)
Basic Respiratory Support (BRS) 7(2%)
Magnesium Sulphate Infusion (Neurological) alone 72(20.5%)
Renal --
Hepatic --
*BRS and BCVS occurring simultaneously during the episode count as a single organ support
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For women who required Level 2 Care only, 
the highest support level location during the 
clinical event is detailed in Table 2.7. Across 
the 15 participating units, over seventy 
percent of these women were treated in an 
obstetric HDU (n=246 of 351, 70.1% one case 
unknown) and over one in six were treated in 
an ICU/CCU (n=64,18.2%). 
In maternity units with fewer than 2,500 
births per year, the number of women who 
required Level 2 Care only was 77. (Highest 
level of support was missing for one location.) 
The majority of women requiring Level 2 Care 
were treated in an ICU/CCU (n=49, 63.6%). 
This proportion decreases in medium-size 
maternities (units with 2,500-6,000 births 
per year) where only 31.8% of women (n=14) 
were provided Level 2 Care in ICU/CCU. In 
tertiary referral hospitals, only one case was 
cared for in ICU/CCU (n=1, 0.4%). Variances 
across units in location of care for women 
requiring Level 2 Care may reflect differences 
in resources available for obstetric Level 2 
Care and a dependence on ICU/CCU facilities. 
In maternity units with 2,500-6,000 births 
per year (medium-sized units), approximately 
half of the women who required Level 2 Care 
were treated in an obstetric HDU (n=20, 
45.5%), and this was the main location for 
Level 2 Care in tertiary referral hospitals 
(n=225, 97.8%). HDU and ICU/CCU facilities 
available to maternity units in Ireland are 
illustrated on page 43 of this report.
Data on transfer details was available for 350 of 
the 351 women requiring Level 2 Care. Of these 
350 cases, 12 (3.4%) were transferred from 
another maternity unit for Level 2 Care. The 
majority of these transfers happened within 
the recipient unit’s HSE hospital network group 
(n=9, 75%).
Location during Level 2 Care
Inter-hospital Transfer
Table 2.7: Highest level support location for women who required Level 2 Care in 15 Irish maternity units, 2016
Note: For women who were treated in more than one care setting during the clinical event, the setting offering the highest level of support is reported. *Highest 
level of support location missing for one case.
No of women 
who required 











All 15 reporting units 351 29(8.3%)* 4(1.1%)* 246(70.1%)* 7(2%)* 64(18.2%)*
Maternity units with 
<2,500 deliveries 77 21(27.3%) 2(2.6%)* 1(1.3%)* 3(3.9%)* 49(63.6%)*
Maternity units with  
2,500-6,000 deliveries 44 7(15.9%) 0(0%) 20(45.5%) 3(6.8%) 14(31.8%)
Tertiary referral hospital 
(>6,000 deliveries) 230 1(0.4%) 2(0.9%) 225(97.8%) 1(0.4%) 1(0.4%)
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38 Clinical Guideline No 25 [2014] The Irish Maternity Early Warning System (IMEWS) Institute of Obstetricians and Gynaecologists, 
Royal College of Physicians of Ireland and Directorate of Clinical Strategy and Programmes, Health Service Executive.
IMEWS
National guidelines recommend the use of the 
Irish Maternity Early Warning System (IMEWS) 
to monitor all women who are clinically 
pregnant or who were delivered within the 
previous 42 days.38 In the majority of 350 cases 
(n=246 of 350, 70.3% unknown for one case), 
an IMEWS was used to monitor women prior 
to commencement of Level 2 Care. Of the 104 
(29.6%) cases where an IMEWS was not used, 
it was reported that the woman was either 
cared for in a location which utilised a different 
monitoring tool (theatre, n=31, 29.8%; labour 
ward, n=45, 43.3%; among others) or admitted 
from home (n=5, 4.8%).
Data on use of an IMEWS chart following 
commencement of Level 2 Care was known for 
332 (of 351). An IMEWS was used during Level 
2 Care in the management of half of the women 
(n=168, 50.6%). In incidences where IMEWS 
was not used during Level 2 Care, a different 
monitoring tool was used in one quarter of the 
cases (n=80, 25%, unknown for 26 cases).
Invasive monitoring
Approximately seventy percent of cases with 
Level 2 Care (n=235, 67.7%, unknown for four 
cases) required invasive monitoring. Arterial 
line monitoring was the most common method 
used (applied in 226 of 235 cases, 96.2%, 
unknown for three cases). Central venous 
catheter (CVP) line was used in 32 cases (13.7% 
of 234, unknown for three cases). Table 2.8 
outlines the incidence of invasive monitoring 
per category of maternal morbidity.
Table 2.8:  Invasive monitoring of women requiring Level 2 Care, 2016
Note: More than one invasive monitoring procedure was required in some cases therefore the percentages sum to more than 100%.
Maternal monitoring prior to and during Level 2 Care





Pregnancy with abortive outcome -- --
Hypertensive disorders 6(18.8%) 98(43.4%)
Obstetric Haemorrhage 15(46.9%) 83(36.7%)
Pregnancy related infection 9(28.1%) 23(10.2%)
Other obstetric complications 0(0%) 5(2.2%)
Unanticipated complications of management 0(0%) 1(0.4%)
Indirect 2(6.3%) 16(7.1%)
Non obstetric complications 2(6.3%) 16(7.1%)
Coincidental -- --
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39 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and  Gynaecologists, 
Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive 
40 Providing equity of critical and maternity care for the critically ill pregnant or recently pregnant woman. Maternal Critical Care Working 
Group. Royal College of Obstetricians and Gynaecologists (2011)
Specialist review during Level 2 Care
Early consultation with anaesthetic staff is 
recommended in cases where there is a concern 
or a high risk of rapid maternal deterioration.39 
The vast majority of women requiring Level 2 
Care were reviewed by a non-obstetric medical 
specialist (n=342, 97.4%), most commonly by 
an anaesthetist (n=333, 94.9%). Figure 2.4 
shows the number of women reviewed per 
type of non-obstetric medical specialist.
Early Pregnancy loss
Some of the cases requiring Level 2 Care (n=7, 
8%) were linked to early pregnancy loss (pre-
viable). Most of these (n=5) were associated 
with obstetric haemorrhage and two further 
cases were associated with pregnancy-related 
infection.
Neonatal outcome/care
Data on neonatal outcome was available for 
339 of the 351 women requiring Level 2 Care. 
Among these, eleven (3.2%) experienced 
perinatal deaths: there were eight stillbirths 
and three early neonatal deaths.
Location of neonatal care during maternal 
Level 2 Care
It has been recommended that models of 
critical care should consider nursing mother 
and baby together unless precluded by a 
clinical indication.40 Of the 317 cases where a 
live born infant was delivered and for which 
data on neonatal care was recorded, the 
majority of infants (n=248, 78.2%) were not 
cared for at the same location as the mother 
during Level 2 Care. 
Among the infants cared for at a different 
location from the mothers (n=248), a total 
of 93 (37.4%) were admitted to SCBU and the 
same number of babies were cared for in the 
NICU. In the remaining cases, care for the infant 
was provided at the postnatal ward (n=50, 
20.1%) or at home (n=11, 4.4%).
In the majority of the 186 cases where 
neonatal admission to SCBU/NICU occurred, 
the indication was for the neonate’s own clinical 
condition (n=141; 75.8%). For the 45 (24.2%) 
infants who did not have a clinical indication 
for admission to the SBCU/NICU, the location 
of maternal care was in an ICU for the majority 
of cases (n=23, 51.1%). In addition, one third 
of mothers in this group was cared for in HDU 
(n=15 of 45, 33.3%).
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Based on the WHO classification system 
for maternal deaths, over three quarters 
(73.7%) of the women requiring Level 3 Care 
were classified as having a direct obstetric 
morbidity, five (26.3%) were due to indirect 
causes and there were no cases attributed 
to a coincidental cause (Table 2.9). This is in 
contrast to national and UK data on maternal 
mortality which has shown that a higher 
proportion of maternal deaths were due to 
indirect obstetric causes compared to direct 
causes.41,42
Table 2.9 demonstrates the number of 
maternal morbidities identified using the three 
different definitions for maternal morbidity: 
the NPEC SMM, the WHO Near Miss (NM) and 
the WHO Severe Maternal Complication (SMC) 
criteria. In contrast to the women requiring 
Level 2 Care only, all of the maternal morbidity 
cases requiring Level 3 Care satisfied the 
criteria for the NPEC SMM (100%) and the WHO 
Near Miss (NM) (100%). The majority of SMM 
cases with Level 3 Care also matched the WHO 
Severe Maternal Complication (SMC) criteria 
(73.7%).
Specific findings for women who required Level 3 Care
Maternal morbidity in women requiring Level 3 Care
41 O’Hare MF, Manning E, Corcoran P, Greene RA on behalf of MDE Ireland. Confidential Maternal Death Enquiry in Ireland, Report for 
2013 - 2015. Cork: MDE Ireland, December 2017.
42 Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives,
Improving Mothers’ Care - Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into
Maternal Deaths and Morbidity 2013–15. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2017.









All (Direct, Indirect and 
Coincidental) 19(100%) 19(100%) 19(100%) 14(73.7%)
Direct 14(73.7%) 14(100%) 14(100%) 11(78.6%)
Pregnancy with abortive outcome* -- -- -- --
Hypertensive disorders 1(5.3%) 1(100%) 1(100%) 1(100%)
Obstetric Haemorrhage 8(42.1%) 8(100%) 8(100%) 8(100%)
Pregnancy related infection 2(10.5%) 2(100%) 2(100%) 2(100%)
Other obstetric complications 1(5.3%) 1(100%) 1(100%) 0(0%)
Unanticipated complications of 
management 2(10.5%) 2(100%) 2(100%) 0(0%)
Indirect 5(26.3%) 5(100%) 5(100%) 3(60%)
Non obstetric complications 5(26.3%) 5(100%) 5(100%) 3(60%)
Coincidental -- -- -- --
Table 2.9: Classification of maternal morbidity in women who required Level 3 Care in 2016 
according to the NPEC Severe Maternal Morbidity (SMM), WHO Near Miss (NM) and WHO Severe 
Maternal Complication (SMC) criteria
Note: Maternal morbidity definition criteria: NPEC SMM, the WHO Near Miss (NM) and the WHO Severe Maternal Complication 
(SMC) criteria.*Includes complications associated with early pregnancy loss.
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Of the 19 women who required Level 3 Care, 
advanced respiratory support (n=17, 89.5%) 
and basic cardiovascular support (BCVS) 
(n=18, 94.7%) were the most common organ 
support provided required for women requiring 
Level 3 Care (Table 2.10). Haematological 
support was required for over half of cases 
(n=11, 57.9%).
For women requiring Level 3 Care, ICU was the 
location of care for all of the 19 cases. In these, 
the ICU facility where care was provided, was 
on a co-located site for the majority of cases 
(n=14, 73.7%): and the remainder (n=5, 
26.3%) were cared for in an off-site location 
within the maternity unit’s HSE regional 
network. Information on whether there was a 
delay in accessing the ICU facility was known 
for 17 of the 19 cases. For 15 of these cases 
(88.2%) there was no delay in accessing the 
ICU facility. 
Data on written interdisciplinary 
communication was available for 16 of the 19 
Level 3 Care cases.  For all but two of these 
16 cases (n=14, 87.5%), a written discharge 
summary of Level 3 Care was received by 
the referring obstetric team. 
Data on what personnel was notified of 
maternal outcome was available for 14 of 
the 16 cases where a written discharged 
communication was available. The referring 
Consultant Obstetrician was notified of 
maternal outcome in all these 14 cases. Among 
this group, the senior midwife was notified of 
maternal outcome in ten cases (71.4%) and the 
women’s GP was notified in five cases (35.7%).
Communication of critical information is an 
essential component of patient care, safety 
and risk management. A key recommendation 
in national guidelines is the necessity for a 
multidisciplinary care plan in the management 
of the critically ill pregnant woman.43
Information on whether a written 
multidisciplinary care plan accompanied 
the maternal transfer details to Level 3 
Care was available for 13 of 19 cases. Of 
these, a written multidisciplinary care plan 
accompanied the maternal transfer details 
in the majority of cases (n=12, 92.3%).
It was reported that in fourteen of the 19 
cases requiring Level 3 Care (unknown for 5 
cases) a discussion between the obstetric 
team and the anaesthetist or critical care 
intensivist occurred prior to admission to 
this level of care. All the 19 women were 
reviewed by an anaesthetist or critical care 
intensivist prior to admission for Level 3 
Care. As such, it is reasonable to assume 
that a discussion between the obstetric 
team and anaesthetist or critical care 
intensivist in all cases.
Organ support required
Location of Level 3 Care
Interdisciplinary communication following Level 3 Care
Communication and specialist review prior to Level 3 Care
Table 2.10: Organ support required during Level 3 Care, 2016
Organ support required N (%)
Advanced Respiratory Support 17(89.5%)
Basic Cardiovascular support (BCVS) 18(94.7%)




Note: More than one organ support is required in Level 3 Care therefore the percentages sum to more than 100%.
43 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and 
Gynaecologists,  Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive
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For over one third (n=7, 36.8%) of the women 
requiring Level 3 Care, an IMEWS was used to 
monitor the woman prior to commencement 
of Level 3 Care. Of the 12 (63.2%) cases 
where an IMEWS was not used for maternal 
monitoring prior to Level 3 Care, it was reported 
that the woman was cared for in a location 
using another physiological monitoring tool 
(theatre, n=11, 91.7% and A&E, n=1, 8.3%).
The use of a specific physiological track and 
trigger tool for maternal monitoring during 
Level 3 Care was used in the majority of cases 
(n=15, 93.8%, unknown for three case).
Almost all (n=18, 94.7%) women required 
invasive monitoring during Level 3 Care. A 
CVP line was required in the majority of cases 
(n=14, 82.4%, unknown for two cases) and an 
arterial line was used in 13 of cases (72.2 %, 
unknown for one case). There were no other 
form of invasive monitoring required.
There were no cases of early pregnancy loss 
(pre-viable) in the women who required Level 
3 Care. Only one of the 19 women experienced 
a stillbirth, with no additional perinatal deaths 
being recorded for maternities requiring Level 
3 Care. 
None of the 17 cases where a live born infant 
was delivered had care provided at the same 
location as the mother during Level 3 Care. 
The majority of infants were admitted to the 
SCBU/NICU (n=10, 58.8%), five infants were 
cared for at home (29.4%) and a further two 
cases (11.8%) were nursed on a postnatal 
ward. 
Of the 10 infants who were admitted to SCBU/
NICU, admission was required for the neonate’s 
own clinical condition in the majority of cases 
(n=5, 55.6%).
Maternal monitoring prior to and during Level 3 Care
Invasive monitoring
Early Pregnancy loss and Neonatal outcome/care
Location of neonatal care during maternal Level 3 Care 
This is the third and final year of the Confidential Audit of Critical Care in Obstetrics in 
Ireland. For the first time data on the provision of Level 2 and Level 3 Care in obstetrics 
has been recorded at national level. One in 114 women required Level 2 Care and one in 
2,127 women required Level 3 Care.
While the location of Level 3 Care was provided in an ICU setting, Level 2 Care was 
provided in a number of settings: overall, Level 2 Care was provided in an obstetric HDU 
in the majority (70%) of cases but there was a higher use of ICU/CCU facilities in smaller 
units. It is evident that a number of women requiring Level 2 Care do not experience organ 
dysfunction as their clinical needs were identified and treated before organ dysfunction 
occurred. The need for higher levels of maternal care is not predictable in approximately 
half of women requiring critical care and thus has implications for resource planning. 
In summary
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Appendix A: Hospital co-ordinators and  
contributors 2016
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed Ms Karen Malocca
Coombe Women and Infants 
University Hospital Ms Julie Sloan
Dr Sharon Sheehan and  
Dr Bridgette Byrne
Cork University  
Maternity Hospital 
Ms Geraldine Hayes, Ms Denise 
Malone, Ms Paulette De Foubert
Prof Richard Greene
Ms Claire Everard
University Hospital  
Kerry
Ms Mary Stack Courtney
Limerick University  
Maternity Hospial
Dr Mendinaro Imcha, Dr Alison 
DeMaio, Ms Bernie Nolan
Ms Sandra O Connor
Letterkenny General  
Hospital
Ms Mary Lynch Ms Evelyn Smith
Mayo University Hospital,  
Castlebar
Ms Diane Brady,  
Ms Pauline Corcoran 
Dr Hilary Ikele,  
Dr Meabh Ní Bhuinneain 
Regional Hospital, Mullingar Ms Marie Corbett
Midland Regional Hospital, 
Portlaoise
Ms Ita Kinsella 
Ms Emma Mullins
National Maternity Hospital Dr Mary Higgins, Dr Tara Rigney and 
Dr Aoife Morris 
Our Lady of Lourdes Hospital, 
Drogheda
Ms Siobhan Weldon, 
Ms Sinead Dow
Dr. S O’Coigligh
Portiuncula University Hospital, 
Ballinasloe
Ms Aisling Dixon,
Ms Priscilla Neilan 
 
Rotunda Hospital, Dublin Dr Sharon Cooley, Dr Mark Hehir,  
Dr Niamh Keating 
Sligo University Hospital Ms Madeleine Munnelly Dr Heather Langan
South Tipperary General Hospital Ms Siobhan Kavanagh
St Luke’s Hospital, Kilkenny Ms Connie McDonagh, 
Ms Fiona Dalton
University Hospital Galway Ms Siobhan Canny
University Hospital Waterford Ms Janet Murphy
Wexford General Hospital Ms Helen McLoughlin
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Dr Bridgette Byrne, Consultant Obstetrician/Gynaecologist, Coombe Women & Infants University Hospital, Dublin
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI.
Dr Sharon Cooley, Consultant Obstetrician & Gynaecologist, The Rotunda Hospital.  
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI.
Ms. Deirdre Daly, Lecturer in Midwifery, Trinity College Dublin.  
Nominated by Deputy Nursing Services Director, HSE.
Ms Anne Fallon, Lecturer in the School of Nursing and Midwifery, National University of Ireland, Galway.
Dr Mary Higgins, Consultant Obstetrician & Gynaecologist, National Maternity Hospital, Holles Street, Dublin 2. 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI.
Ms Claire Jones, Patient Representative
Ms. Ita Kinsella, Clinical Midwife Manager 2, Midland Regional Hospital Portlaoise.
Ms. Janet Murphy, Advanced Midwife Practitioner, Waterford Regional Maternity Hospital.  
Nominated by Deputy Nursing Services Director, HSE.
Dr Meabh Ni Bhuinneain, Consultant Obstetrician & Gynaecologist, Mayo General Hospital, Castlebar, Co. Mayo. 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI.
Dr Cliona Murphy, Consultant Obstetrician & Gynaecologist, Coombe Women & Infants University Hospital,  
Dolphins Barn, Dublin 8.  
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI.
Prof. Richard Greene, Consultant Obstetrician/Gynaecologist, Cork University Maternity Hospital
Chair, Director of the National Perinatal Epidemiology Centre.
Ms. Edel Manning, Research Midwife, National Perinatal Epidemiology Centre, Severe Maternal Morbidity Audit Project 
Manager
Mr. Paul Corcoran PhD, Epidemiologist, National Perinatal Epidemiology Centre.
Appendix B: Severe Maternal Morbidity Group 
Members
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Appendix C: NPEC Governance Committee
Chair: Dr. Michael Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital
Professor Tom Clarke, Consultant Neonatologist, Rotunda Hospital (Retired)
Dr Sharon Cooley, Institute of Obstetrics and Gynaecology Representative
Ms. Marie Cregan, Patient Representative, University College Cork
Professor Declan Devane, Chair of Midwifery, National University of Ireland, Galway
Dr. Geraldine Gaffney, Senior Lecturer, National University of Ireland, Galway
Professor Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital,  
Director of the National Perinatal Epidemiology Centre
Dr. Heather Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital
Dr. Rhona Mahony, Master, National University Hospital
Professor Fergal Malone, Master, The Rotunda Hospital
Professor Eleanor Molloy, Faculty of Paediatrics Representative
Ms. Connie McDonagh, Clinical Midwife Manager 3, St. Luke’s General Hospital
Dr. Mary O’Mahony, Specialist in Public Health Medicine, HSE
Dr. Sharon Sheehan, Master, Coombe Woman and Infants University Hospital
Ms Sheila Sugrue, National Lead Midwife, Office of the Nursing & Midwifery Services
Ms Collette Tully, NOCA Executive Director, National Office of Clinical Audit
Ms Ann O’Byrne, Chair of the national Designated Midwifery Officer Group - Home Births
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Appendix D: National Office of Clinical Audit (NOCA) 
endorsement of the Severe Maternal Morbidity in 
Ireland Annual Report 2016 
 
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 
Tel: + (353) 1 402 8577 
Email: auditinfo@noca.ie 
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
          01st June 2018 
 
Severe Maternal Morbidity in Ireland, Annual Report 2018 
 
Dear Professor Greene, 
 
I acknowledge receipt of the Severe Maternal Morbidity in Ireland Report 2016 and confirm 
following circulation to the NOCA Governance Board and feedback garnered from our membership, 
we are delighted to endorse this report.  
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
 
Please accept this as formal endorsement from the NOCA Governance Board of the Severe Maternal 








Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
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SEVERE MATERNAL MORBIDITY IN IRELAND
Notification Form:  2016
Hospital Name _____________________________________________________
Completed by _____________________________________________________
(Please print name and staff grade)
Date of clinical event://
Time of onset of clinical event::
Woman’s details: 
Age    Height at booking   ____________cm
BMI 
Weight at booking ____________kg
Parity:        +
(Status prior to delivery)
Date of delivery: // Gestation at delivery/pregnancy end 
(or pregnancy end)  (Completed weeks)
1a. Ethnic group: White Irish Irish Traveller
Any other White background Please specify country of origin_____________________
Asian or Asian Irish Black or Black Irish
Other, including mixed ethnic backgrounds: Not recorded     
1b. Was the care of this woman transferred from another hospital Yes No
If yes please indicate timing of transfer in relation to pregnancy status:
Woman transferred with fetus in-utero Woman transferred following delivery of baby  
Name of referring maternity unit: _________________________________
Appendix E 
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2
2a. Did the woman smoke at booking?         Yes please specify quantity _____________
No Not recorded
2b. Did she give up smoking during pregnancy? Yes No       Not recorded N/A
3. Did the woman drink alcohol at booking?     Yes .No      Not recorded
4. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?
None recorded       Prior to this pregnancy        During this pregnancy 
5 Obstetric history: Did the woman have a previous caesarean section      Yes No
6. This Pregnancy
6 a. Was this pregnancy the result of infertility treatment? Yes No Unknown
6 b. If yes please specify method of fertility treatment __________________________________
7. Was this an early pregnancy loss?   No Yes: MiscarriageYes: Ectopic pregnancy 
If early pregnancy loss please go to question 10
8 Delivery Details
8a. Onset of Labour:              Spontaneous         Induced         Never in labour
8b. Lie of fetus at delivery     Longitudinal    Oblique  Transverse 
8c. Presentation at delivery             Cephalic             Breech                          Other
8d. Number of fetuses/babies in this delivery 
9. Mode of delivery:
Baby 1 Baby 2* Baby 1 Baby 2*
i) Spontaneous vaginal 
delivery
vi) Elective LSCS not 
in labour
ii) Assisted vaginal  
breech delivery
vii) Elective LSCS in 
labour
iii) Ventouse vaginal  
delivery
viii) Emergency LSCS 
not in labour
iv) Non-rotational forceps  
vaginal delivery
ix) Emergency LSCS 
in labour








Please answer yes or no as applicable
Baby Outcomes Baby 1 Baby 2 Baby 3
Birth weight in grams
Intubation following delivery 
Transferred to SBCU/NICU
*Early Neonatal Death 
*Late Neonatal Death  
Intrauterine death ≥ 500g and/or ≥ 24 weeks gestation
11.Maternal Care Details
11a. Location of Care during clinical event:
Please tick all that apply
On the ward    Delivery Suite Theatre     High dependency unit      ICU/CCU
11b. Level of Care Required:
Please indicate the highest level of care required during the clinical event:
Level of care Definition Please tick one box
Level 0: Normal ward care Care of low risk pregnant women 
Level 1: Additional monitoring or 
intervention, or step down from 
higher level of care
Patients at risk of their condition 
deteriorating and needing a higher level 
of observation or those recently 
relocated from higher levels of care
Level 2: Single Organ Support** Patients requiring invasive monitoring/
intervention* including support for a 
single failing organ system (excluding 
advanced respiratory support).
Level 3: Advanced respiratory 
support alone, or support of two 
or more organ systems**
Patients requiring advanced respiratory 
support (mechanical ventilation) alone or 
basic respiratory support along with 
support of at least one additional organ.
* invasive monitoring/intervention includes the use of arterial and CVP lines 
**Examples of level 2 and 3 care in the critically ill pregnant or recently pregnant woman are outlined 
below
Level 2 examples
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous Positive Airway 
Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP)
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; Arterial line used for 
pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to guide therapy
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-hypertensive/vasoactive 
drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output
Neurological Support: Magnesium infusion to control seizures / prophylaxis of eclampsia in severe PET
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such that transplantation 
is being considered
Level 3 examples
Advanced Respiratory Support: Invasive mechanical ventilation
Support of two or more organ systems: Renal support and BRS; BRS/BCVS and an additional organ supported; Intracranial pressure 
monitoring
Reference:  Saravanakumar K, Davies L, Lewis M, Cooper GM.. High dependency care in an obstetric setting in the UK. Anaesthesia 
2008:63, 1081–6.
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4
Maternal Morbidity Category
(See page 5 for definitions)
Please tick all that apply
1. Major obstetric haemorrhage (MOH)  Estimated blood loss ≥ 2500mls
*please identify the criteria met for MOH in the opposite 
column accordingly. More than 1 can apply                 
Transfused with  ≥  5  units of blood
Received treatment for coagulopathy 
2. Uterine rupture
3. Peripartum hysterectomy (PH)
*please specify indication for PH in text box below
4. Eclampsia
5. Renal or liver dysfunction
6. Pulmonary oedema









*please specify indication for admission
Duration of ICU care in days/ part days
                                                      (e.g. 1.5 days)
16. Other severe morbidity, please specify
17. Interventional radiology (IR)                                                                                                                                                                 
Please use this space to enter any additional relevant information.
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Please notify all categories of Severe Maternal Morbidity, as 
outlined above,  occurring during pregnancy or up to 42 days 
following delivery, miscarriage, termination of pregnancy or ectopic 
pregnancy.
Maternal Morbidity Definitions
1 Major obstetric haemorrhage
Estimated blood loss ≥ 2500ml, or transfused 5 or more units of blood 
or received treatment for coagulopathy (Fresh Frozen Plasma; 
Fibrinogen Concentrate Substitution Therapy; Platelets)  
(Also includes ectopic pregnancy meeting these criteria)
2 Uterine rupture
A complete separation of the wall of the pregnant uterus, with or 
without expulsion of the fetus, involving rupture of membranes at the 
site of the uterine rupture or extension into uterine muscle separate 
from any previous scar, and endangering the life of the mother or 
fetus.
Excluded: any asymptomatic palpable or visualised defect (e.g. 
dehiscence noted incidentally at caesarean delivery)
3 Peripartum hysterectomy Peripartum hysterectomy
4 Eclampsia Seizure associated with antepartum, intrapartum or postpartum symptoms and signs of pre-eclampsia
5 Renal or liver dysfunction
Acute onset of biochemical disturbance, urea >15mmol/l, 
creatinine>400mmol/l, AST/ALT >200u/l
6 Pulmonary oedema
Clinically diagnosed pulmonary oedema associated with acute 
breathlessness and O2 saturation <95%, requiring O2, diuretics or 
ventilation
7 Acute respiratory dysfunction
Requiring intubation or ventilation for >60 minutes (not including 
duration of general anaesthetic)
8 Pulmonary embolism
Increased respiratory rate (>20/min), tachycardia, hypotension. 
Diagnosed as “high” probability on V/Q scan or positive spiral chest 
CT scan. Treated by heparin, thrombolysis or embolectomy
9 Cardiac arrest No detectable major pulse
10 Coma Including diabetic coma. Unconscious for >12 hours
11 Cerebro-vascular event
Stroke, cerebral/cerebellar haemorrhage or infarction, subarachnoid 
haemorrhage, dural venous sinus thrombosis
12 Status epilepticus Constant or near constant state of having seizures that last 30mins or more
13 Septicaemic shock Shock (systolic blood pressure <80) in association with infection. No other cause for decreased blood pressure. Pulse of 120bpm or more
14 Anaesthetic problem Aspiration, failed intubation, high spinal or epidural anaesthetic
15 ICU/CCU admission Unit equipped to ventilate adults. Admission for one of the above problems or for any other reason. Includes CCU admissions
16 Other severe morbidity Other severe morbidity, e.g. amniotic fluid embolism
17 Interventional radiology Received planned (a) or unplanned (b) interventional radiology
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Appendix F: National Guidelines for the critically ill 
woman in obstetrics43
52  Severe Maternal Morbidity in Ireland Annual Repor t 2014
Appendix G: National Guidelines for the critically ill 
woman in obstetrics28
SMM Report 2014 080716.indd   52 08/07/2016   10:20
43 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, 
Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive  
Appendix F: National Guidelines for the critically 
ill woman in obstetrics43
43 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, Royal College of 
Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive
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Appendix G: NPEC Critical Care Form 2016 Detailed 
Case Assessment Level 2 and Level 3
CONFIDENTIAL AUDIT of 
Critical Care in Obstetrics in Ireland 
2016
Detailed Case Assessment Form of Level 2 & Level 3 
Critical Care in Obstetrics
Please ensure that a Severe Maternal Morbidity 
Notification Form is completed along with this 
booklet
Please return completed forms to:
Edel Manning
Project manager
National Perinatal Epidemiology Centre
Department of Obstetrics and Gynaecology
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Rationale for this confidential Audit
As part of the on-going confidential clinical audit on severe maternal morbidity in Ireland, the National Perinatal 
Epidemiology Centre (NPEC) aims to conduct an audit on pregnant or recently pregnant women (this includes women 
in the postpartum period and women following early pregnancy loss) requiring Level 2 and Level 3 Critical Care.
Please see Table1 on page 8 for definitions.
Objectives of this audit are:
 To identify the number of women requiring Level 2 and Level 3 Care in the Irish maternity services
 To identify the location where critical care is provided
 To identify resources and other issues impacting on access to and provision of Level 3 care 
 To evaluate the use of ICU/CCU facilities within the Irish Maternity Services.
Please note obstetric patients who are admitted to ICU will be subject to the Intensive Care National Audit and 
Research Centre, (ICNARC) audit. The NPEC confidential audit on critical care in obstetrics compliments the ICNARC 
audit from an obstetric view point. There is no duplication of data collection.
The NPEC is sincerely grateful for your contribution to this audit
Inclusion criteria for the audit of Critical Care in Obstetrics:
All pregnant or recently pregnant women (up to and including 42 days following delivery, miscarriage, termination of 
pregnancy or ectopic pregnancy) who require Level 2 or Level 3 Care.
Guidelines for completing notification and case assessment forms 
• Definitions and examples of levels of care are outlined in Table1 on page 8
• Abbreviations are outlined in Table 2 on page 8  
• Please mark the category box on the top of page 1 indicating Level of critical care provided/sequence of care
• ‘Not known’ codes should be used as sparingly as possible
• Please ensure that the NPEC Severe Maternal Morbidity Notification Form is completed (either online 
via the NPEC online database or in hard copy form) along with this form 
• Relevant sections to be completed for Level 2 and Level 3 Care are outlined below:
Thank you for taking the time to complete this form
• Section 1 & 2 (questions 1- 17)
• Ensure Severe Maternal Morbidity 
Notification Form has been completed 
Women requiring 
Level 2 Care only
• Sections 1 & 3 (questions 1 - 6 and 18 - 33 )
• Ensure Severe Maternal Morbidity 
Notification Form has been completed 
Women requiring 
Level 3 Care only
• Sections 1 & 2 & 3 (questions 1 - 33 )
• Ensure Severe Maternal Morbidity 
Notification Form has been completed 
Women requiring 
Level 2 and Level 3 
Care
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(Please print name and staff grade)
1. Category of the level of Critical Care required in this clinical event
If applicable please indicate the sequence of critical care provided in this clinical event:
Level 2 Care only
Level 3 Care only
Level 2 Care followed by Level 3 Care 
Level 3 Care followed by Level 2 Care 
Level 2 Care followed by Level 3 Care 
followed by Level 2
2. Date of Clinical Event://
Day Month Year
3. Time of Event: : (24 hour clock) 
4a. Maternal age: 4b. Parity: (Status prior to delivery) + 
5. Did this woman have a medical/surgical or psychiatric disorder that pre-existed this pregnancy?
Yes  No 
If yes, please specify disorder(s) ________________________________________________________
6. Was this pregnancy identified as ‘high risk’ during the antenatal period? Yes  No 
Section 2: Level 2 Care
7. Duration of Level 2 Care in days/ part days:                 Days
                                                      (e.g.1.5 days)
8. Location where Level 2 Care was provided in this clinical event (Please tick all that apply):
Ward  (Please specify type, maternity/gynaecology/general)___________________________
Delivery Suite  Theatre  Dedicated HDU /Maternity Hospital 
Dedicated HDU/ General Hospital  ICU  CCU
Other, please specify _____________________________
NPEC Reference Number: 
_________________________
(As issued from the online 
database)
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9. Location of maternal care prior to Level 2 Care 
Home Ward (Please specify type: maternity/gynaecology/general)___________________
Delivery Suite  Theatre  Dedicated HDU/Maternity Hospital 
Dedicated HDU/General Hospital  ICU CCU
Other, please specify _____________________________
Inter-hospital Transfer
10a. Was this woman transferred from another hospital for Level 2 Care? 
Yes  No  (If no, please go to question 11a)
*Inter-hospital transfer only: 
10b. Was the referring hospital within your HSE regional hospital network? Yes  No 
10c. Please indicate below all heath care professionals in attendance during transfer (please specify grade):
Anaesthetist ________________ Obstetrician  _____________________
Midwife________________   Nurse___________ Other, please specify___________________
11a. Please identify the organ system that required support during Level 2 Care 
(Please refer to page 8 for examples of organ support required in Level 2 Care)
__________________________________________________________________________________________
__________________________________________________________________________________________
11b. If a Magnesium Sulphate infusion was transfused, what was the primary indication for the transfusion:
Maternal: treatment for eclamptic seizure Fetal neuroprotection only
Maternal: prophylaxis of eclampsia in severe pre-eclampsia
12. Please specify the main clinical diagnosis during Level 2 Care in this clinical event:
__________________________________________________________________________________________
__________________________________________________________________________________________
Maternal monitoring prior to commencement of Level 2 Care
13a. Was an IMEWS chart used prior to commencement of Level 2 Care? 
Yes  No (please go to question 13d)
13b. If yes, on average how often were physiological observations recorded? 
(e.g. every 30 minutes)                        Every                 hours                     minutes
13c. What was the highest IMEWS score recorded prior to commencement of Level 2 Care? 
_________________________________________________________________________________________
13d. If an I-MEWS chart was not used prior to commencement of Level 2 Care, please indicate why not?
_________________________________________________________________________________________
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Maternal monitoring during Level 2 Care:
14a. Was an IMEWS chart used during Level 2 Care? Yes  No 
14b. Was the patient monitored using another specific physiological track and trigger system/tool?
Yes  No  (please go to question 14d)
14c. Were patient specific triggers identified using this system/ tool? Yes  No 
14d. Was invasive monitoring used? Yes  No 
(If yes, please tick all that apply)
CVP line  Arterial line  Other  please specify_______________  
Specialist review:
15. Was the woman reviewed by a non-obstetric medical specialist? Yes  No 
(If yes, please tick all that apply)
Anaesthetist  Critical Care Intensivist  Haematologist  General surgeon
Physician ____________________ Neurosurgeon  Cardiologist Psychiatrist 
(Please specify speciality)
Neonatal Care:
16a. Location of neonate during maternal Level 2 Care
Not applicable/not delivered or early pregnancy loss  With mother  (go to question 17a)
Not with mother  please specify location _______________________________ 
16b If neonatal care was transferred to SBCU/NICU, was SBCU/NICU care required for the neonate’s own 
clinical condition? Yes  No 
Discharge from Level 2 Care
17a Please indicate the level of care required at discharge from Level 2 Care:
Level 0 Level 1  Level 3 
17b Please identify the discharge location of this women following Level 2 Care:
Ward (Please specify type, maternity/gynaecology/general)____________________
Delivery Suite  Theatre  Dedicated HDU Maternity Hospital 
Dedicated HDU General Hospital  ICU  CCU Maternal Death 
Other, please specify ______________________
Please use this space to enter any relevant issues regarding provision of Level 2 Care in this event
Section 3: Level 3 Care
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Section 3: Level 3 Care
18. Duration of Level 3 care in days/part days (e.g. 1.5 days):                           Days       
19a. Please identify the location where Level 3 Care was provided
ICU  CCU Other, please specify ______________________
19b. Where was the ICU/CCU care facilitated? 
Co-located site Off maternity hospital site/ within the HSE regional network
Off maternity hospital site/ not within the regional network but within the HSE* In another jurisdiction*
*If applicable, please specify reason for transfer of care outside your unit’s HSE regional network
_________________________________________________________________________________________
20. Was there a delay in accessing an ICU/CCU bed? Yes  No 
If yes, what was the estimated time delay in hours? 
21. Location of care prior to commencement of Level 3 Care: 
Ward  (Please specify type, maternity/gynaecology/general)________________________
Delivery Suite  Theatre  Dedicated HDU Maternity Hospital 
Dedicated HDU General Hospital  ICU  CCU
Other, please specify _____________________________
22. What was the highest level of care provided prior to commencement of Level 3 Care? 
23a. Was the woman reviewed by an Anaesthetist or Critical Care Intensivist prior to ICU/CCU admission?
Yes (If yes, please go to question 24a)   No  Unknown 
23b. Was there a discussion between the Obstetric Team and the Anaesthetist or Critical Care Intensivist 
prior to admission?
Yes  No  Unknown 
Maternal monitoring prior to commencement of Level 3 Care
24a. Was an IMEWS chart used prior to commencement of Level 3 Care? 
Yes  No  (If no, please go to question 24d)
24b. If yes, on average how often were physiological observations recorded? 
(e.g. every 30 minutes)                       Every                   hours                       minutes
24c. What was the Highest IMEWS score recorded prior to commencement of Level 3 Care?
________________________________________________________________________________________
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24d. If an IMEWS chart was not used prior to commencement of Level 3 Care, please indicate why not?
_________________________________________________________________________________________
Maternal monitoring during Level 3 Care
25a. Was the patient monitored using a specific physiological track and trigger system/tool?
Yes  No Unknown
Invasive monitoring:
25b. Was invasive monitoring used during Level 3 Care? Yes  No  Unknown 
(If yes, please tick all that apply)
CVP line  Arterial line  Other  please specify_______________  
 
Communication/ transfer details:
26. Did a written multidisciplinary care plan accompany the maternal transfer details to location of Level 3 
Care?
Yes  No  Unknown 
If yes, which of the following were identified in the care plan?
(Please tick all that apply)
Consultant Obstetrician Consultant Anaesthetist ICU/CCU Intensivist Senior Midwife
Neonatologist  Other, please specify ___________________
27. Please indicate all healthcare professionals in attendance during transfer to location of Level 3 Care 
(Please specify grade)
Anaesthetist ________________ Obstetrician  _____________________
Midwife__________________ Other ___________________
28. Please specify the main clinical diagnosis prior to commencement of Level 3 Care  
_________________________________________________________________________________________
_________________________________________________________________________________________
29. Please specify the clinical diagnosis at discharge from Level 3 Care 
_________________________________________________________________________________________
_________________________________________________________________________________________
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30. Please indicate in the Table below any organ dysfunction identified and organ support required both at 
commencement of and during Level 3 Care (Please tick all that apply)









Basic Respiratory support (Definition page 8)
Advanced respiratory support (mechanical ventilation)  
Neurological Dysfunction/Support:
Prolonged unconsciousness (lasting ≥ 12 hours)…….








Use of continuous Cardiac Vasoactive Drugs……...
Severe hypoperfusion (lactate ≥ 4 mmol/L or severe
acidosis (PH <7.1)………………………………………
Renal Dysfunction/Support:
Oligouria, non-responsive to fluids or diuretics
Dialysis for Acute Renal Failure 
Severe acute azotemia (creatinine ≥ 300 µmol/ml or ≥
3.5 mg/dL)
Coagulation/Haematological Dysfunction/Support:
Disseminated Intravascular Coagulopathy (DIC) …..
Severe thrombocytopenia (< 50, 000 platelets/ml).....
Transfusion of blood or red cells (≥ 5 units)…………
Hepatic Dysfunction:
Jaundice in the presence of pre-eclampsia, eclampsia
Severe Acute Hyperbilirubinemia (bilirubin > 100 µmol 
/L or > 6.0 mg/dL)
Uterine Dysfunction: Uterine haemorrhage or 
infection leading to hysterectomy…………………..
Sepsis or Severe Systemic infection     
Multi Organ Failure     
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Location of neonate during Level 3 Care
31 a. Location of Neonatal Care:
Not delivered or early pregnancy loss (please go to question 32) With mother (please go to question 32)
Not with mother, please specify location _________________________(please go to 31b)
31b. If neonatal care was transferred to SBCU/NICU, was SBCU/NICU care required for the neonate’s own 
clinical condition? Yes  No 
32. Discharge details from Level 3 Care
Please indicate the level of care required at discharge from Level 3 Care? 
Level 0 Care Level 1 Care  Level 2 Care Maternal Death
Where was the discharge destination of this women following Level 3 Care?
Ward  (Please specify type, maternity/gynaecology/general)________________________
Delivery Suite  Dedicated HDU Maternity Hospital  Dedicated HDU General Hospital 
Maternal Death Other, please specify _____________________________
33a Was a written discharge summary of Level 3 Care received by the referring Obstetric Team/Unit?
Yes  (Please answer 33b) No  Unknown 
33b Please indicate all personnel notified of maternal outcome following Level 3 Care:
Referring Consultant Obstetrician Consultant Neonatologist Consultant Anaesthetist
Critical Care Intensivist Physicianplease specify speciality____________________
Senior Midwife General Practitioner Public Health Nurse Consultant Psychiatrist
Other  please specify_______________  
Thank you for taking the time to complete this form
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Definitions of Levels of Care
Table 1: Definitions of Level of Care
Level of care Definition
Level 0: Normal ward care Care of low risk pregnant women 
Level 1: Additional monitoring or intervention, 
or step down from higher level of care
Patients at risk of their condition deteriorating and needing a 
higher level of observation or those recently relocated from 
higher levels of care
Level 2: Single Organ Support** Patients requiring invasive monitoring */ intervention
including support for a single failing organ system (excluding 
advanced respiratory support).
Level 3: Advanced respiratory support alone, 
or support of two or more organ systems**
Patients requiring advanced respiratory support (mechanical 
ventilation) alone or basic respiratory support along with 
support of at least one additional organ.
* Invasive monitoring includes the use of arterial and CVP lines 
Examples of Critical Care, Level 2 and Level 3:
Level 2 Care:
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous 
Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP)
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; 
Arterial line used for pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to 
guide therapy
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-
hypertensive/vasoactive drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output
Neurological Support: Magnesium Sulphate infusion to control seizures / other
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such 
that transplantation is being considered
Level 3 Care:
Advanced Respiratory Support: Invasive mechanical ventilation
Support of two or more organ systems: Renal support and BRS;
BRS/BCVS and an additional organ supported (BRS and BCVS occurring simultaneously during the episode count as 
a single organ support);
Intracranial pressure monitoring
References: Saravanakumar K, Davies L, Lewis M, Cooper GM. High dependency care in an obstetric setting in the 
UK. Anaesthesia 2008:63, 1081-6
Table 2: Abbreviations  
Abbreviation  Definition  
CCU Coronary Care Unit  
HDU  High Dependency Unit  
ICU  Intensive Care Unit  
I-MEWS Irish Maternity Early Warning System  
 
If you have questions or difficulties regarding any aspect of the form, please do not hesitate to contact
Edel Manning at: e.manning@ucc.ie, telephone: (021) 4205042
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Appendix H: Classification of maternal mortality 
WHO Application of ICD-10
The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM44
Maternal Death Deaths of women while pregnant or within 42 days of the end of the 
pregnancy* from any cause related to or aggravated by the pregnancy or 
its management, but not from accidental or incidental causes
Direct Deaths resulting from obstetric complications of the pregnant state 
(pregnancy, labour and puerperium), from interventions, omissions, 
incorrect treatment or from a chain of events resulting from any of the 
above.
Indirect Deaths resulting from previous existing disease, or disease that 
developed during pregnancy and which was not the result of direct 
obstetric causes, but which was aggravated by the physiological effects 
of pregnancy.
Coincidental Deaths from unrelated causes which happen to occur in pregnancy or the 
puerperium.
*Includes giving birth, ectopic pregnancy, miscarriage or termination of pregnancy.
Direct causes Examples of potential causes of deaths
1. Pregnancies withabortive outcome Abortion, miscarriage, ectopic pregnancy and other conditions leading to 
maternal death and a pregnancy with abortive outcome
2. Hypertensive disorders Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth 
and the puerperium
3. Obstetric Haemorrhage Obstetric diseases or conditions directly associated with haemorrhage
4. Pregnancy related infection Pregnancy-related, infection-based diseases or conditions
5. Other obstetric complications All other direct obstetric conditions not included in groups to 1–4
6. Unanticipated complications of 
management Indirect causes
Severe adverse effects and other unanticipated complications of medical 
and surgical care during pregnancy, childbirth or the puerperium
Indirect causes
7. Non obstetric complications Non-obstetric conditions  
e.g. Cardiac disease, Neurological disease, Infection not as a directresult 
of pregnancy, Other indirect causes
8. Unknown /Undetermined Maternal death during pregnancy, childbirth and the puerperium where 
the underlying cause is unknown or was not determined
9. Coincidental causes Death during pregnancy, childbirth and the puerperium due to external 
causes
44 World Health Organisation The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM 2012 France.
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Appendix I: The WHO organ-dysfunction criteria 
defined as Near Miss45
Severe maternal complication Definition
Cardiovascular dysfunction shock, use of continuous vasoactive drugs, cardiac arrest, cardio-
pulmonary resuscitation, severe hypoperfusion (lactate >5mmol/L or 
>45mg/dL) or severe acidosis (pH<7.1)
Respiratory dysfunction acute cyanosis, gasping, severe tachypnea (respiratory rate>40 bpm), 
severe bradypnea (respiratory rate<6 bpm), severe hypoxemia (P AO2/
FiO2<200 O2 saturation <90% for ≥60m in) or intubation and ventilation 
not related to anaesthesia
Renal dysfunction oliguria non responsive to fluids or diuretics, dialysis for acute renal 
failure or severe acute azotemia (creatinine ≥300umol/ml or ≥3.5 mg/
dL)
Coagulation/haematologic dysfunction failure to form clots, massive transfusion of blood or red cells (≥ 5 
units) or severe acute thrombocytopenia (<50,000 platelets/ ml)
Hepatic dysfunction jaundice in the presence of pre-eclampsia, severe acute 
hyperbilirubinemia (bilirubin>100umol/L or >6.0mg/dL)
Neurologic dysfunction prolonged unconsciousness / coma (lasting >12 hours), stroke, status 
epilepticus / uncontrollable fits or global paral
Uterine dysfunction/hysterectomy haemorrhage or infection leading to hysterectomy
Multiple organ dysfunction
45 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011  
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Appendix J: The WHO classification of severe maternal 
complications46
Severe maternal complication Definition
Severe postpartum haemorrhage Genital bleeding after delivery, with at least one of the following: 
perceived abnormal bleeding (≥ 1000 ml) or any bleeding with 
hypotension or blood transfusion.
Severe pre-eclampsia Persistent systolic blood pressure of 160 mmHg or more or a diastolic 
blood pressure of 110 mm Hg; proteinuria of 5 g or more in 24 hours, 
oliguria of < 400 ml in 24 hours; and HELLP syndrome or pulmonary 
oedema. Excludes eclampsia.
Eclampsia Generalised fits in a patient without a previous history of epilepsy. 
Includes coma in pre eclampsia.
Severe systemic infection or
sepsis
Presence of fever (body temperature > 38 degrees C), a confirmed 
or suspected infection (e.g. chorioamnionitis, septic abortion, 
endometritis, pneumonia), and at least one of the following: heart rate 
> 90, respiratory rate > 20, leukopenia (white blood cells < 4000), 
leucocytosis (white cells > 12 000).
Uterine rupture Rupture of uterus during labour confirmed by laparotomy.
46  Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011
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Appendix K: The Robson Ten Group Classification 
System47
47  Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. Licence: CCBY-NC-SA3.0IGO
The 10 groups of the Robson Classification 47
47 Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
Appendix K 
The 10 groups of the Robson Clas ification 47
47 Robson Classification: Implemen ation Manual. Geneva: World H alth Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
Appendix K 
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